Inergetics (NRTI) S-1 1 Aug 14 IPO registration Financial data

Document_And_Entity_Informatio

Document And Entity Information	3 Months Ended
	Mar. 31, 2014
Document Information [Line Items]	'
Document Type	'S-1
Amendment Flag	'false
Document Period End Date	31-Mar-14
Trading Symbol	'NRTI
Entity Registrant Name	'INERGETICS INC
Entity Central Index Key	'0000072170
Entity Filer Category	'Smaller Reporting Company

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current Assets:	'	'	'
Cash	$106,165	$106,773	$8,846
Accounts receivable, net	319,098	472,297	0
Receivable from the Technology Business Tax Certificate Transfer Program	0	3,357,144	2,209,715
Deferred cost of goods sold	456,741	569,036	0
Inventories, net	1,087,506	420,186	4,176
Prepaid expenses	566,099	447,355	522,041
Total Current Assets	2,535,609	5,372,791	2,744,778
Patents and intangible assets, net	148,997	149,391	4,942
Goodwill	135,000	135,000	0
Deposits	195,806	421,191	2,299
Total Assets	3,015,412	6,078,373	2,752,019
Current Liabilities:	'	'	'
Accounts payable and accrued expenses	3,420,437	5,089,488	2,846,181
Deferred Revenue	1,010,178	1,269,470	0
Obligations to be settled in stock	939,888	699,085	564,500
Customer prepayments	'	0	39,970
Derivative liability	1,332,000	318,000	227,000
Short-term debt, net of unamortized debt discount	1,038,257	1,276,358	1,144,375
Short-term debt to affiliates, net of unamortized debt discount	4,219,846	2,843,728	2,441,622
Total current liabilities	11,960,606	11,496,129	7,263,648
Long-term debt	151,098	103,912	39,584
Long-term debt, net to affiliates	0	1,425,522	0
Total liabilities	12,111,704	13,025,563	7,303,232
Commitments and Contingencies	'	'	'
Preferred stock, Convertible Series G, authorized 400,000 par $1, stated Value $50: 217,528 and 198,074 shares issued and outstanding	9,280,126	8,743,284	7,147,465
Preferred stock, par value $1:	'	'	'
Common stock, par value $0.001; authorized 2,000,000,000 shares; issued and outstanding 73,229,104 and 62,461,448 shares, respectively	73,230	62,462	48,708
Additional paid-in capital	70,619,370	68,789,021	68,606,679
Accumulated deficit	-89,264,063	-84,737,002	-80,549,110
Total Stockholders' Deficit	-18,376,418	-15,690,474	-11,698,678
Total Liabilities and Stockholders' Deficit	3,015,412	6,078,373	2,752,019
Convertible Series B	'	'	'
Preferred stock, par value $1:	'	'	'
Preferred stock	130,282	130,282	130,282
Total Stockholders' Deficit	'	130,282	130,282
Cumulative Series C	'	'	'
Preferred stock, par value $1:	'	'	'
Preferred stock	64,763	64,763	64,763
Total Stockholders' Deficit	'	64,763	64,763
Convertible Series D	'	'	'
Preferred stock, par value $1:	'	'	'
Preferred stock	0	0	0
Total Stockholders' Deficit	'	0	0
Convertible Series E	'	'	'
Preferred stock, par value $1:	'	'	'
Preferred stock	0	0	0
Total Stockholders' Deficit	'	0	0
Convertible Series F	'	'	'
Preferred stock, par value $1:	'	'	'
Preferred stock	0	0	0
Total Stockholders' Deficit	'	$0	$0

CONDENSED_CONSOLIDATED_BALANCE1

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Preferred stock, Convertible Series G, authorized	400,000	400,000	200,000
Preferred stock, Convertible Series G, par value	$1	$1	$1
Preferred stock, Convertible Series G, stated value	$50	$50	$50
Preferred stock, Convertible Series G, shares issued	217,528	198,074	150,938
Preferred stock, Convertible Series G, shares outstanding	217,528	198,074	150,938
Common stock, par value	$0.00	$0.00	$0.00
Common stock, authorized	2,000,000,000	2,000,000,000	2,000,000,000
Common stock, issued	73,229,104	62,461,448	48,707,103
Common stock, outstanding	73,229,104	62,461,448	48,707,103
Convertible Series B	'	'	'
Preferred stock, par value	$2	$2	$2
Preferred Stock, shares issued	65,141	65,141	65,141
Preferred stock, shares outstanding	65,141	65,141	65,141
Cumulative Series C	'	'	'
Preferred stock, par value	$1	$1	$1
Preferred Stock, shares issued	64,763	64,763	64,763
Preferred stock, shares outstanding	64,763	64,763	64,763
Convertible Series D	'	'	'
Preferred stock, par value	$1	$1	$1
Preferred Stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Convertible Series E	'	'	'
Preferred stock, par value	$1	$1	$1
Preferred Stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0
Convertible Series F	'	'	'
Preferred stock, par value	$1	$1	$1
Preferred Stock, shares issued	0	0	0
Preferred stock, shares outstanding	0	0	0

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Total Revenues	$479,802	$6,775	$847,834	$91,873
Cost of Goods Sold	362,603	4,770	603,006	86,327
Gross Profit	117,199	2,005	244,828	5,546
Research and development	4,408	0	44,090	45,578
Selling, general and administrative expense	3,140,720	1,391,896	6,491,671	5,590,867
Total operating expenses	3,145,128	1,391,896	'	'
Loss from operations	-3,027,929	-1,389,891	-6,290,933	-5,630,899
Other Income (Expense)	'	'	'	'
Amortization of debt discount	-133,353	-37,054	-444,450	-255,583
Gain on extinguishment of debt	15,591	0	0	-736,000
Gain (loss) on fair market valuation of derivatives	-1,014,000	-71,000	-91,000	870,000
Interest and financing cost, net	-367,370	-80,807	-760,132	-733,495
Total Other Income (Expense)	-1,499,132	-188,861	-1,248,604	-855,078
Gain incurred in connection with troubled debt restructuring, net	41,578	'	46,978	0
Loss before Provision for Income taxes	-4,527,061	-1,578,752	-7,539,537	-6,485,977
State taxes	0	3,499	3,351,645	2,209,715
Net Loss	-4,527,061	-1,582,251	-4,187,892	-4,276,262
Preferred Dividend	258,438	441,900	1,560,200	1,175,350
Net Loss applicable to common shareholders	($4,785,499)	($2,024,151)	($5,748,092)	($5,451,612)
Net Loss per Common Share - Basic and Diluted	($0.08)	($0.04)	($0.10)	($0.15)
Weighted Average Number of common shares outstanding - Basic and Diluted	64,008,126	48,265,436	55,307,453	37,314,265

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Parenthetical) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation	$914,479	$611,500

Consolidated_Statement_of_Stoc

Consolidated Statement of Stockholder's Equity (USD $)	Total	Series B Preferred Stock	Series C Preferred Stock	Series D Preferred Stock	Series E Preferred Stock	Series F Preferred Stock	Series G Preferred Stock	Common Stock	Additional Paid-in Capital	Common Stock Subscribed	Accumulated Deficit
Beginning Balance at Dec. 31, 2011	($4,786,743)	$130,282	$64,763	$0	$0	$0	$5,621,665	$27,781	$65,281,614	$360,000	($76,272,848)
Beginning Balance (in shares) at Dec. 31, 2011	'	65,141	64,763	0	0	0	120,827	27,780,205	'	2,240,200	'
Issuance of common stock for services	3,284,250	'	'	'	'	'	1,045,250	11,395	2,227,605	'	'
Issuance of common stock for services (in shares)	'	'	'	'	'	'	20,500	11,395,000	'	'	'
Issuance of common stock for interest	339,741	'	'	'	'	'	221,000	895	117,846	'	'
Issuance of common stock for interest (in shares)	'	'	'	'	'	'	4,420	895,184	'	'	'
Issuance of common stock for compensation	265,301	'	'	'	'	'	'	1,143	264,158	'	'
Issuance of common stock for compensation (in shares)	'	'	'	'	'	'	'	1,142,514	'	'	'
Warrants issued for compensation	487,500	'	'	'	'	'	'	'	487,500	'	'
Issuance of common stock subscribed	0	'	'	'	'	'	'	2,240	357,760	-360,000	'
Issuance of common stock subscribed (in shares)	'	'	'	'	'	'	'	2,240,200	'	-2,240,200	'
Preferred stock converted into common stock	0	'	'	'	'	'	-1,050,800	5,254	1,045,546	'	'
Preferred stock converted into common stock (in shares)	'	'	'	'	'	'	-21,016	5,254,000	'	'	'
Sale of Preferred stock	135,000	'	'	'	'	'	135,000	'	'	'	'
Sale of Preferred stock (in shares)	'	'	'	'	'	'	2,700	'	'	'	'
Preferred stock dividend	0	'	'	'	'	'	1,175,350	'	-1,175,350	'	'
Preferred stock dividend (in shares)	'	'	'	'	'	'	23,507	'	'	'	'
Net loss	-4,276,262	'	'	'	'	'	'	'	'	'	-4,276,262
Ending Balance at Dec. 31, 2012	-11,698,678	130,282	64,763	0	0	0	7,147,465	48,708	68,606,679	0	-80,549,110
Ending Balance (in shares) at Dec. 31, 2012	'	65,141	64,763	0	0	0	150,938	48,707,103	'	0	'
Issuance of common stock for services	324,270	'	'	'	'	'	122,000	1,637	200,633	'	'
Issuance of common stock for services (in shares)	'	'	'	'	'	'	4,000	1,637,500	'	'	'
Issuance of common stock for interest	560,248	'	'	'	'	'	153,740	2,852	403,656	'	'
Issuance of common stock for interest (in shares)	'	'	'	'	'	'	4,307	2,851,711	'	'	'
Issuance of common stock for compensation	505,509	'	'	'	'	'	'	6,391	499,118	'	'
Issuance of common stock for compensation (in shares)	'	'	'	'	'	'	'	6,390,625	'	'	'
Warrants issued for compensation	206,700	'	'	'	'	'	'	'	206,700	'	'
Preferred stock converted into common stock	0	'	'	'	'	'	-741,950	3,934	738,016	'	'
Preferred stock converted into common stock (in shares)	'	'	'	'	'	'	-15,739	3,934,750	'	'	'
Debt converted into equity	55,188	'	'	'	'	'	55,188	'	'	'	'
Debt converted into equity (in shares)	'	'	'	'	'	'	2,044	'	'	'	'
Issuance of preferred stock for business acquisition	140,000	'	'	'	'	'	140,000	'	'	'	'
Issuance of preferred stock for business acquisition (in shares)	'	'	'	'	'	'	8,000	'	'	'	'
Loss on extinguishment of debt	0	'	'	'	'	'	358,641	'	-358,641	'	'
Loss on extinguishment of debt (in shares)	'	'	'	'	'	'	14,360	'	'	'	'
Preferred stock dividend	0	'	'	'	'	'	1,560,200	'	-1,560,200	'	'
Preferred stock dividend (in shares)	'	'	'	'	'	'	31,204	'	'	'	'
Stock retired	0	'	'	'	'	'	-52,000	-1,060	53,060	'	'
Stock retired (in shares)	'	'	'	'	'	'	-1,040	-1,060,241	'	'	'
Net loss	-4,187,892	'	'	'	'	'	'	'	'	'	-4,187,892
Ending Balance at Dec. 31, 2013	($15,690,474)	$130,282	$64,763	$0	$0	$0	$8,743,284	$62,462	$68,789,021	'	($84,737,002)
Ending Balance (in shares) at Dec. 31, 2013	'	65,141	64,763	0	0	0	198,074	62,461,448	'	'	'

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Cash Flows from Operating Activities:	'	'	'	'
Net Loss	($4,527,061)	($1,582,251)	($4,187,892)	($4,276,262)
Adjustments to Reconcile Net Loss to Net Cash Used In Operations	'	'	'	'
Loss on fair market valuation of derivatives	1,014,000	71,000	91,000	-870,000
Depreciation and amortization	394	144	'	'
Common Stock issued for financing expenses	3,082	0	406,508	339,741
Preferred Stock issued for financing expenses	36,378	0	'	'
Amortization of intangible assets	'	'	1,551	576
Gain on extinguishment of debt	-15,591	0	-46,978	0
Accretion of debt discount	133,353	37,054	444,450	255,583
Amortization of prepaid expenses paid for in stock	0	0	0	2,577,470
Stock issued for services	86,905	42,000	202,270	136,700
Stock issued for compensation	1,323,883	450,600	505,509	17,300
Warrant grants issued for compensation and services	'	'	206,700	457,500
Equity instruments issued with debt greater than debt carrying amount	'	'	0	736,000
Inventory reserve	'	'	-49,200	2,179
Changes in Assets and Liabilities	'	'	'	'
Decrease in accounts receivable	153,199	0	-472,297	1,216
Decrease in receivable from Technology Business Tax Certificate Transfer Program	3,357,144	2,209,715	-1,147,429	-2,209,715
(Increase) in inventories	-667,320	-100,924	-366,810	130,418
Decrease in deferred cost of goods sold	112,295	0	-569,036	0
(Increase) Decrease in prepaid expenses	-205,649	346,587	3,044	448,919
(Increase) in note receivable	0	-5,680	'	'
(Increase) Decrease in deposits	225,385	-4,666	-418,892	0
(Decrease) in accounts payable and accrued expenses	-543,714	-262,632	2,326,763	807,182
(Decrease) in deferred Revenue	-259,292	0	1,269,470	0
Customer prepayments	'	'	-39,970	0
Net Cash Provided by Operating Activities	227,391	1,200,947	-1,841,239	-1,445,193
Cash Flows from Investing Activities	'	'	'	'
Acquisition of business	0	-75,000	-100,000	0
Purchase of intangible assets	'	'	-41,000	0
Net Cash Used in Investing Activities	0	-75,000	-141,000	0
Cash Flows from Financing Activities	'	'	'	'
Proceeds from debt	300,000	130,000	3,331,688	1,487,522
Proceeds from the sale of preferred stock	'	'	0	135,000
Repayment of debt	-528,000	-1,171,522	-1,251,522	-171,000
Net Cash Used in Financing Activities	-228,000	-1,041,522	2,080,166	1,451,522
Net Increase in Cash	-609	84,425	97,927	6,329
Cash at beginning of period	106,773	8,846	8,846	2,517
Cash at end of period	106,165	93,271	106,773	8,846
Supplemental Disclosure of Cash Flow information:	'	'	'	'
Interest Expense	213,621	85,575	86,169	4,861
Income Taxes	0	3,499	5,500	0
Issuance of G shares as Preferred dividend (4,135 and 8,838 shares)	258,438	441,900	'	'
Business Acquisition	'	'	'	'
Supplemental Disclosure of Cash Flow information:	'	'	'	'
Stock issued for services	0	140,000	'	'
Convertible Preferred Stock	'	'	'	'
Supplemental Disclosure of Cash Flow information:	'	'	'	'
Issuance of G shares as Preferred dividend (4,135 and 8,838 shares)	'	'	55,188	0
Convertible Preferred Stock Series G shares issued for financing	'	'	153,740	221,000
Common Stock	'	'	'	'
Supplemental Disclosure of Cash Flow information:	'	'	'	'
Stock issued for services	0	84,000	'	'
Prepaid Expense	'	'	'	'
Supplemental Disclosure of Cash Flow information:	'	'	'	'
Stock issued for services	$240,803	$0	'	'

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Stock issued for services, shares	'	8,037,500
Issuance of redeemable preferred stock shares	4,135	8,838

SUMMARY_OF_SIGNIFICANT_ACCOUNT

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]	'	'
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	'	'
	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Organization	Organization and business
	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the Company or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., is a holding company for its subsidiary Millennium Biotechnologies, Inc. ("Millennium").	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the “Company” or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., which is the holding company for its subsidiary Millennium Biotechnologies, Inc. (the “Subsidiary” or "Millennium").
	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey.  Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science.  Millennium’s principal source of revenue is from sales of its nutraceutical supplements, Resurgex Select® and Resurgex Essential™ and Resurgex Essential Plus™ which serve as a nutritional support for immuno-compromised individuals undergoing medical treatment for chronic debilitating diseases. Millennium has developed Surgex for the sport nutritional market. The Company acquired Bikini Ready®, a leader in weight loss lifestyle solutions and SlimTrim™, the affordable, premium value diet brand. The Company has a licensing agreement to sell the Martha Stewart Essentials line of supplements.   The Company’s efforts going forward will focus on sales of Martha Stewart Essentials™ line of supplements, Surgex in powder and pill forms as well as powder and pills for Bikini Ready and pills for SlimTrim.	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey. Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science. Millennium’s principal source of revenue is from sales of its nutraceutical supplements.
	The accompanying unaudited condensed consolidated financial statements include the accounts of Inergetics, Inc. and its subsidiary. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Certain information in footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States of America has been condensed or omitted pursuant to such principles and the financial results for the periods presented may not be indicative of the full year’s results. The Company believes that the disclosures are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the December 31, 2013 audited financial statements and the accompanying notes thereto filed with the Securities and Exchange Commission on Form 10-K.	Reclassifications
	Principles of Consolidation	Certain reclassifications have been made to the 2012 financial statements to conform to the consolidated 2013 financial statement presentation. These reclassifications had no effect on net losses or cash flows as previously reported.
	The condensed consolidated financial statements include the accounts of the Company and its subsidiary.  All significant inter-company transactions and balances have been eliminated.	Principles of Consolidation
	Use of Estimates	The consolidated financial statements include the accounts of the Company and its subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation.
	The preparation of the financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.	Use of Estimates
	Goodwill	The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates and judgments on our experience and on various assumptions we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions.
	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment.	Cash and Cash Equivalents
	Revenue Recognition	Cash and all highly liquid investments with a maturity of three months or less from the date of purchase, including money market mutual funds, short-term time deposits, and government agency and corporate obligations, are classified as cash and cash equivalents.
	Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which occurs at shipping (F.O.B. terms).   Upon shipment to various customers when all performance obligations are met and collectability is reasonably assured revenue is recognized.   Upon shipment to specific customers with the right of return the Company defers revenues as returns are not reasonably estimable.   As of March 31, 2014 and December 31, 2013, deferred revenue totaled $1,010,178 and $1,268,470, respectively.	Accounts Receivable
	Deferred Revenue and Deferred Cost of Goods Sold	The Company continuously monitors collections and payments from our customers and regularly adjusts credit limits of customers based upon payment history and a customer’s current credit worthiness, as judged by us. There was no allowance for doubtful accounts as of December 31, 2013 and 2012.
	Deferred revenue consists substantially of amounts billed or payments received in advance of revenue recognition. Deferred cost of goods sold as of March 31, 2014 and December 31, 2013 of $456,741 and $569,036, respectively, related to deferred product revenues includes direct product costs. Once all revenue recognition criteria have been met, the deferred revenues and associated cost of goods sold are recognized.	Receivable from Technology Business Tax Certificate Transfer Program
	Income Taxes	The receivable is from the Company selling the New Jersey State net operating loss carry forwards. The Company was able to transfer $3,357,144 of total available tax benefits of $3,357,144 for the year ended December 31, 2013. The receivable was collected on January 23, 2014. The Company was able to transfer $2,209,715 of total available tax benefits of $5,187,471 for the year ended December 31, 2012. The receivable was collected on January 14, 2013. The Company paid a fee of $302,143 and $198,875 for the years ended December 31, 2013 and 2012, respectively, in connection with the approval of the Tax Certificate Transfer Program.
	The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.	Goodwill
	Loss Per Common Share	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment. At the conclusion of our test the Company has realized that there has not been any impairment.
	Net loss per share, in accordance with the provisions of ASC 260, “Earnings Per Share” is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the period. Common Stock equivalents have not been included in this computation since the effect would be anti-dilutive. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock and convertible debt are not considered in the diluted income (loss) per share calculation since the effect would be anti-dilutive.	Property and Equipment
	Fair Value of Financial Instruments	Property and equipment are stated at cost less accumulated depreciation. Depreciation, which includes amortization of assets under capital leases, is calculated using the straight-line method over the estimated useful lives of the assets: 3-8 years for machinery and equipment, leasehold improvements are amortized over the shorter of the estimated useful lives or the underlying lease term. Repairs and maintenance expenditures which do not extend the useful lives of related assets are expensed as incurred. As of December 31 2012 and 2013, all property and equipment has been fully depreciated.
	For financial instruments including cash, accounts receivable, prepaid expenses, debt, accounts payable and accrued expenses, the carrying values approximated their fair value.	Patents
	Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.	Patents are capitalized and amortized over 240 months. Amortization expense was $1,551 and $576 for 2013 and 2012, respectively.
		Evaluation of Long-Lived Assets
		Long-lived assets are assessed for recoverability on an ongoing basis as impairment indicators arise. In evaluating the fair value and future benefits of long-lived assets, their carrying value would be reduced by the excess, if any, of the long-lived asset over management’s estimate of the anticipated undiscounted future net cash flows of the related long-lived asset.
		Revenue Recognition
		Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which generally occurs at shipping (F.O.B. terms). Upon shipment, the Company has no further performance obligations and collection is reasonably assured as the majority of sales are paid for prior to shipping.
		Discounts are reductions to invoiced amounts offered to customers for payment within a specified period and are estimated upon sale utilizing historic customer payment experience.
		Consistent with industry practice, the Company maintains a return policy that allows customers to return product within a specified period prior and subsequent to the expiration date. The Company’s estimate of the provision for returns is generally based upon historic experience with actual returns.
		Price adjustments, which include shelf stock adjustments, are credits issued to reflect decreases in the selling prices of products. Shelf stock adjustments are based upon the amount of product which the customer has remaining in its inventory at the time of the price reduction. Decreases in selling prices are discretionary decisions made by the Company to reflect market conditions. Amounts recorded for estimated price adjustments are based upon specified terms with direct customers, estimated launch dates of competing products, estimated declines in market price and, in the case of shelf stock adjustments, estimates of inventory held by the customer.
		Certain retailers require guaranteed sales. Revenue is recognized as sales are made to the retail consumer.
		Advertising costs
		Advertising costs are charged to operations when incurred. Advertising expense was $8,157 and $261 for the years ended December 31, 2013 and 2012, respectively.
		Shipping and Handling Costs
		Shipping costs of $43,299 and $8,065 are included in cost of sales for the years ended December 31, 2013 and 2012, respectively. Handling costs of $44,467 and $37,358 are included in general and administrative expenses for the years ended December 31, 2013 and 2012, respectively.
		Stock and Warrant Based Compensation
		Stock and warrant based compensation is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the requisite employee service period (generally the vesting period of the grant). Compensation expense is recognized based on the estimated grant date fair value method using the Black-Scholes valuation model. The Company account for the issuance of stock and warrants for services based on the estimated fair value of options and warrants using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly based on the subjective assumptions used in the pricing model.
		We account for the issuance of stock and warrants for services from non-employees based on an estimate of the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly if we were to use different assumptions.
		The Company issued 1,140,000 warrants, that vest over four years, during the year ended December 31, 2013 for an expense of $206,700 and 7,500,000 warrants, that vested over three years, for an expense of $457,500 during the year ended December 31, 2012. The Company did not issue any stock options during the year ended December 31, 2013 and 2012, respectively.
		Income Taxes
		The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. Accordingly, for Federal and state income tax purposes, the benefit for income taxes has been offset entirely by a valuation allowance against the related federal and state deferred tax assets for the years ended December 31, 2013 and 2012.
		Loss Per Common Share
		Basic and diluted loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods. Potential common shares used in computing diluted earnings per share related to stock options, warrants, convertible preferred stock and convertible debt which, if exercised, would have an anti- dilutive effect on earnings per share, and there for have not been included Anti-dilutive securities not included in net loss per share calculations for the years presented include:
			December 31,
		Potentially dilutive securities:	2013		2012
		Convertible debt and accrued interest		10,751,345		10,775,363
		Liability of shares to be issued		3,330,000		2,300,000
		Convertible Preferred stock		49,713,545		37,929,545
		Outstanding time-based warrants		19,323,406		18,190,906
		Fair Value of Financial Instruments
		The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The levels are defined as follows:
		Level 1 – quoted prices for identical instruments in active markets;
		Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and
		Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
		For financial instruments including cash, prepaid expenses and other current assets, short-term debt, accounts payable and accrued expenses, it was assumed that the carrying values approximated fair value because of their short-term maturities.
		Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
		Research and Development
		Research and development costs are expensed as incurred.

GOING_CONCERN_AND_LIQUIDITY_IS

GOING CONCERN AND LIQUIDITY ISSUES	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Going Concern [Abstract]	'	'
GOING CONCERN	'	'
	2 . GOING CONCERN AND LIQUIDITY ISSUES	2. GOING CONCERN
	The Company’s future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities, and upon additional financing.  Management believes they can raise the appropriate funds needed to support their business plan and develop an operating company which is cash flow positive.	The Company’s future success is dependent upon its ability to achieve profitable operations and generate cash from operating activities, and upon additional financing.  Management believes they can raise the appropriate funds needed to support their business plan and develop an operating, cash flow positive company.
	However, the Company has a working capital deficit, significant debt outstanding, incurred substantial net losses for the Three months ended March 31, 2014 and 2013 and has accumulated a deficit of approximately $ 89 million at March 31, 2014. The Company has not been able to generate sufficient cash from operating activities to fund its ongoing operations. There is no guarantee that the Company will be able to generate enough revenue and/or raise capital to support its operations.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.	However the Company has incurred substantial net losses for the years ended December 31, 2013 and 2012 and has accumulated a deficit of approximately $85 million at December 31, 2013 and $81 million at December 31, 2012. The Company has not been able to generate sufficient cash from operating activities to fund its ongoing operations. There is no guarantee that the Company will be able to generate enough revenue and/or raise capital to support its operations.  These factors raise substantial doubt about the Company’s ability to continue as a going concern.
	The condensed consolidated financial statements do not include any adjustments relating to the recoverability or classification of recorded assets and liabilities that might result should the Company be unable to continue as a going concern.	The consolidated financial statements do not include any adjustments relating to the recoverability or classification of recorded assets and liabilities that might result should the Company be unable to continue as a going concern.

BUSINESS_ACQUISITION

BUSINESS ACQUISITION	3 Months Ended			12 Months Ended
	Mar. 31, 2014			Dec. 31, 2013
Business Acquisition Cost Of Acquired Entity Purchase Prices [Abstract]	'			'
BUSINESS ACQUISITION	'			'
	3.        BUSINESS ACQUISITION			3. BUSINESS ACQUISITION
	On January 9, 2013 (the “Acquisition date”), the Company entered into a definitive agreement pursuant to which it acquired, through its Millennium Biotechnologies, Inc. wholly-owned subsidiary, the trademark of Bikini Ready® and the brand SlimTrim™. Under the agreement the Company acquired the URL’s, formula and customer list. Under the terms of this agreement the Company paid $ 100,000 cash and 8,000 shares of Series G preferred stock valued at $ 140,000 .			On January 9, 2013 (the “Acquisition date”), the Company entered into a definitive agreement pursuant to which it acquired, through its Millennium Biotechnologies, Inc. wholly-owned subsidiary, the trademark of Bikini Ready® and the brand SlimTrim™. Under the agreement the Company acquired the URL’s, formula and customer list. Under the terms of this agreement the Company paid $100,000 cash and 8,000 shares of Series G preferred stock valued at $140,000.
	The transaction was accounted for as a purchase business combination. The results from operations for the period from acquisition date to March 31, 2014 have been included in the Company’s condensed consolidated statement of operations. Pro forma information with respect to the acquisition are not included in these financial statements as the information is not material.			The transaction was accounted for as a purchase business combination. We account for business combinations in accordance with the acquisition method. The acquisition method of accounting requires that assets acquired and liabilities assumed be recorded at their fair values on the date of a business acquisition. The excess of the purchase price over the fair value of assets acquired is recognized as goodwill. Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but with the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income. Our consolidated financial statements and results of operations reflect an acquired business from the completion date of an acquisition. The results from operations for the period from acquisition date to December 31, 2013 have been included in the Company’s consolidated statement of operations. Pro forma information with respect to the acquisition are not included in these financial statements as the information is not material.
	In accordance with generally accepted accounting principles, intangible assets are recorded at fair values as of the date of the transaction. The Company’s allocation to identifiable intangible assets and liabilities according to their respective fair values, is as follows:			In accordance with generally accepted accounting principles, intangible assets are recorded at fair values as of the date of the transaction. The Company’s allocation to identifiable intangible assets and liabilities according to their respective fair values, is as follows:
	Intangible assets, trademarks	$	100,000	Intangible assets, trademarks	$	100,000
	Intangible assets, customer list		5,000	Intangible assets, customer list		5,000
	Goodwill		135,000	Goodwill		135,000
	Purchase Price	$	240,000	Purchase Price	$	240,000
	Intangible assets with estimated useful lives are amortized over a 5 year period. The goodwill is not amortized for financial statement purposes in accordance with generally accepted accounting principles.			Intangible assets with estimated useful lives are amortized over a 5 year period. The goodwill is not amortized for financial statement purposes in accordance with generally accepted accounting principles.

CONCENTRATIONS_OF_BUSINESS_AND

CONCENTRATIONS OF BUSINESS AND CREDIT RISK	3 Months Ended		12 Months Ended
	Mar. 31, 2014		Dec. 31, 2013
Risks and Uncertainties [Abstract]	'		'
CONCENTRATIONS OF BUSINESS AND CREDIT RISK	'		'
	4	CONCENTRATIONS OF BUSINESS AND CREDIT RISK	4. CONCENTRATIONS OF BUSINESS AND CREDIT RISK
	The Company maintains cash balances in several financial institutions which are insured by the Federal Deposit Insurance Corporation up to certain federal limitations.		The Company maintains cash balances in several financial institutions which currently are insured by the Federal Deposit Insurance Corporation. Balances in these accounts may, at times, exceed the federally insured limits.
	The Company provides credit in the normal course of business to customers located throughout the U. S. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends, and other information.		The Company provides credit in the normal course of business to customers and performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends, and other information.
			For the year ended December 31, 2013, three significant customers (defined as contributing at least 10%) accounted for 55% (31%, 13%, and 11%) of net sales. For the year ended December 31, 2012, one significant customer accounted for 57% of net sales. The loss of any of these customers could have a material adverse effect on our business.

INVENTORIES

INVENTORIES	3 Months Ended					12 Months Ended
	Mar. 31, 2014					Dec. 31, 2013
Disclosure - Inventories [Abstract]	'					'
INVENTORIES	'					'
	5. INVENTORIES					5. INVENTORIES
	Inventories are stated at the lower of cost or market on a first in, first out basis. Inventories consist of work-in-process, raw materials, finished goods, and packaging for the Company’s Martha Stewart Essentials, SURGEX®, RESURGEX ESSENTIAL ®, Bikini Ready® and SlimTrim™ product lines. Cost-of-goods sold are calculated using the average costing method. Inventories consist of the following:					Inventories are stated at the lower of cost or market and consist of finished goods and packaging for the Company’s Surgex™, Bikini Ready™, SlimTrim and Martha Stewart™ Essentials product lines. Cost-of-goods sold are calculated using the weighted average costing method. Inventories consisted of the following:
		March 31,		December 31,			December 31,
		2014		2013			2013		2012
	Finished Goods	$	1,029,452	$	378,472	Finished Goods	$	378,472	$	2,344
	Packaging		58,054		41,714	Work-in-process		-		49,200
			1,087,506		420,186	Packaging		41,714		1,832
	Less: Reserve for obsolescence		-		-			420,186		53,376
	Total	$	1,087,506	$	420,186	Less: Reserve for obsolescence		-		-49,200
						Total	$	420,186	$	4,176

PREPAID_EXPENSES

PREPAID EXPENSES	3 Months Ended
	Mar. 31, 2014
Prepaid Expenses Disclosure [Abstract]	'
PREPAID EXPENSES	'
	6. PREPAID EXPENSES
	Prepaid expenses are for services that have been paid in advance primarily with stock that are amortized over the life of the contract. The agreements pertain to pricing structure, distribution, warehousing, inventory management, financial advisory services, pro athlete endorsements and licensing agreements.

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	3 Months Ended					12 Months Ended
	Mar. 31, 2014					Dec. 31, 2013
Payables and Accruals [Abstract]	'					'
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	'					'
	7. ACCOUNTS PAYABLE AND ACCRUED EXPENSES					6. ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses consisted of the following:					Accounts payable and accrued expenses consisted of the following:
		March 31,		December 31,			December 31,
		2014		2013			2013		2012
	Accounts payable	$	2,527,020	$	2,866,017	Accounts payable	$	2,866,017	$	1,224,313
	Owed to officer		5,650		16,088	Accrued interest		1,016,584		669,035
	Accrued interest		411,269		1,016,584	Accrued rent expense		135,874		135,874
	Accrued rent expense		135,874		135,874	Accrued salaries, bonuses and payroll taxes		824,492		612,712
	Accrued salaries, bonuses and payroll taxes		143,648		824,492	Accrued professional fees		230,433		204,247
	Accrued professional fees		196,976		230,433	Owed to officers		16,088		-
		$	3,420,437	$	5,089,488		$	5,089,488	$	2,846,181

SHORT_TERM_DEBT_NET_OF_DEBT_DI

SHORT TERM DEBT, NET OF DEBT DISCOUNT	3 Months Ended
	Mar. 31, 2014
Short-Term Debt, Other Disclosures [Abstract]	'
SHORT TERM DEBT, NET OF DEBT DISCOUNT	'
	8. SHORT TERM DEBT, NET OF DEBT DISCOUNT
	In the first Three months of 2014, the Company realized gross proceeds of $ 300,000 in new cash. Proceeds from the sale of its 12% to 15.0% twelve month Unsecured Convertible Notes, in the aggregate original principal amount of $ 300,000 (the “Notes”) to accredited investors (the “Investors”).  Interest on the outstanding principal balance of the Notes is payable upon maturity of the note. The outstanding principal balance of the Notes and all accrued but unpaid interest thereon may be converted at any time at the option of each Investors into shares of Common Stock at the Conversion Price of $ .20 per share.  The Company may prepay the Notes at any time without penalty to the Investors.
	Unsecured Notes, net debt discount, consist of the following:
		March 31,		December 31,
		2014		2013
	Unsecured Convertible Notes	$	1,261,867	$	1,450,333
	Debt discount		-72,512		-70,063
			1,189,355		1,380,270
	Less long term portion		151,098		1,276,358
	Short term portion	$	1,038,257	$	103,912
	The Company committed to issue 561,918 shares of common stock for origination fees during the three months ended March 31, 2014 and recorded a debt discount of $ 77,207.
	Gain on Troubled Debt Restructuring
	2014 Modification of Debt
	The following debt instruments were modified in 2014. The modification of debt included the addition of a conversion feature therefore requiring the Company to record the transaction in accordance with ASC 470 “Debt” modification of debt accounting.
	At December 31, 2013, the Company had promissory notes issued to one affiliated investor with an outstanding balance of $2,000,000, which were due on demand. During January 2014, the Company reached an agreement with the investor to extend the debt for twelve months. At the date of extension, the debt payable was $2,000,000. The fair value of the new debt is $1,791,713. As of March 31, 2013 the loss on debt modification of $208,287 has been included in the Stockholders’ Deficit.
	At December 31, 2013, the Company had promissory notes issued to three accredited investors with an outstanding balance of $249,535, which were due on demand. During January 2014, the Company reached an agreement with the investors to extend the debt for six to twelve months. At the date of extension, the debt payable was $249,535. The fair value of the new debt is $223,548. The conversion rate on the new convertible note is $0.20 per share of common stock. As of March 31, 2013 the loss on debt modification of $25,987 has been included in the Statement of Operations. The loss incurred with debt restructuring approximates $0.00 per share.
	At December 31, 2013, the Company had Notes issued to two accredited investors in March 2004 and August 2013 with an outstanding principal and interest balance of $111,978, which were due on demand. In January 2014, the Company reached an agreement with the investors to convert into 275,000 shares of common stock plus $43,725 in cash as full settlement. The debt and accrued interest was valued at $111,978 which exceeded the fair market value of the common stock and cash by $41,5778. The difference resulted in a gain on troubled debt restructuring of $41,578 has been included in the Statement of Operations in the three months ended March 31, 2014. The gain incurred with debt restructuring approximates $0.00 per share.
	The Secured Promissory Unit Note issued in November 2009 with the principal amount outstanding of $ 85,726 and accrued interest of $59,163 as of March 31, 2014 is in default due to non-payment. The Secured Promissory Unit Note in the original amount of $85,726 and interest accrued thereon was originally repayable in five quarterly installments beginning 18 months after issue.

SHORT_TERM_DEBT_RELATED_PARTIE

SHORT TERM DEBT - RELATED PARTIES, NET OF DEBT DISCOUNT	3 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
SHORT TERM DEBT - RELATED PARTIES, NET OF DEBT DISCOUNT	'
	9. SHORT TERM DEBT – RELATED PARTIES, NET OF DEBT DISCOUNT
	In the three months ended March 31, 2014, the Company realized gross proceeds of $ 100, from the sale of its 12.0 % six month Unsecured Convertible Notes and Secured Promissory Notes, in the aggregate original principal amount of $100,000 (the “Notes”) to an accredited investor (the “Investor”).  Interest on the outstanding principal balance of the Notes is payable upon maturity of the note. The Company may prepay the Notes at any time without penalty to the Investors.
	The Company issued 125,000 shares of common stock for origination fees during the three months ended March 31, 2014, in connection with this debt and recorded a debt discount of $26,740.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	3 Months Ended									12 Months Ended
	Mar. 31, 2014									Dec. 31, 2013
Fair Value Disclosures [Abstract]	'									'
FAIR VALUE MEASUREMENTS	'									'
	10. FAIR VALUE MEASUREMENTS									7. FAIR VALUE MEASUREMENTS
	The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis									The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis:
		Fair Value at								December 31, 2013	Level I		Level II		Level III		Total
		March 31,		Fair Value Measurement Using
		2014		Level 1		Level 2		Level 3		Derivative liability						318,000		318,000
	Derivative liability – Conversion Feature	$	1,332,000		-		-	$	1,332,000	Total liabilities	$	-	$	-	$	318,000	$	318,000
		$	1,332,000		-		-	$	1,332,000
										December 31, 2012	Level I		Level II		Level III		Total
		Fair Value at
		December 31,		Fair Value Measurement Using						Derivative liability						227,000		227,000
		2013		Level 1		Level 2		Level 3		Total liabilities	$	-	$	-	$	227,000	$	227,000
	Derivative liability – Conversion Feature	$	318,000		-		-	$	318,000
		$	318,000		-		-	$	318,000	Liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level3):
	The table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities (Derivative liability – Conversion Feature) for the three months ended March 31, 2014:										Derivative
											Liabilities
		March 31,								1-Jan-13	$	-227,000
		2014								Loss on fair market valuation of derivatives		-91,000
	Balance at December 31, 2013	$	318,000							31-Dec-13	$	-318,000
	Derivative converted into Equity		-8,000
	Change in fair market value of Conversion Feature		1,022,000
	Balance at March 31, 2014	$	1,332,000

WARRANTS

WARRANTS	3 Months Ended							12 Months Ended
	Mar. 31, 2014							Dec. 31, 2013
Stock Warrants Disclosure [Abstract]	'							'
WARRANTS	'							'
	11. WARRANTS								11	OPTIONS AND WARRANTS
	Warrant activity for the three months ended March 31, 2014 is as follows:							In February 2000, Millennium adopted its 2001 Stock Option Plan ("The 2001 Plan"). The 2001 Plan provides that certain options granted thereunder are intended to qualify as "Incentive Stock Options" (ISO) within the meaning of Section 422A of the United States Internal Revenue Code of 1986, while non-qualified options may also be granted under the Plan. The Plan provided for the grant of options for up to 500,000 shares. The purchase price per common stock deliverable upon exercise of each ISO shall not be less than 100% of the fair market value of the common stock on the date such option is granted. If an ISO is issued to an individual who owns, at the time of grant, more than 10% of the total enhanced voting power of all classes of Millennium’s common stock, the exercise price of such option shall be at least 110% of the fair market value of the common stock on the date of grant and the term of the option shall not exceed five years from the date of grant. The purchase price of shares subject to non-qualified stock options shall be determined by a committee established by the Board of Directors with the condition that such prices shall not be less than 85% of the fair market value of the common stock at the time of grant. Millennium had no options issued pursuant to this Plan as of December 31, 2013 and 2012, respectively.
			Weighted
			Average		Remaining	Aggregate					December 31, 2013							December 31, 2012
		Number of	Exercise		Contractual Term In	Intrinsic						Shares		Weighted				Shares		Weighted
		Warrants	Price		Months	Value								Average						Average
	Outstanding at December 31, 2013	19,323,406	$	0.2	63	$	300,000							Exercise						Exercise
														Price						Price
	Granted	-		-	55		-
								Warrants outstanding - beginning of year				18,190,906		$	0.225				7,631,544	$	0.404
	Exercised	-531,262		0.104	-		-	Warrants exercised				-			-				-		-
								Warrants granted				1,140,000			0.185				10,587,500		0.129
	Expired or cancelled	-		-	-		-	Warrants expired				-7,500			60				-28,138		12,446
	Outstanding and exercisable at March 31, 2014	18,792,144	$	0.197	Nov-92	$	1,878,967	Warrants outstanding - end of year				19,323,406		$	0.2				18,190,906	$	0.225
								Warrants price range at end of year			$0.10 - $16.00								$0.10 - $60.00
								Warrants price for exercised shares				$0.00							$0.00
								The following table summarizes information about fixed-price warrants outstandings
								Range of Exercise			Number		Average		Weighted		Number			Weighted
								Prices			Outstanding at		Remaining		Average		Exercisable at			Average
											December 31,		Contractual		Exercise Price		December 31,			Exercise Price
											2013		Life				2012
								$	0.1		7,500,000		47 Mo’s		$	0.1			7,500,000	$	0.1
								$	0.17		8,033,406		92 Mo’s		$	0.17			7,533,406	$	0.17
								$	0.2		3,727,500		16 Mo’s		$	0.2			3,087,500	$	0.2
								$	16		62,500		72 Mo’s		$	16			62,500	$	16
								$	60		-				$	60			7,500	$	60
											19,323,406								18,190,906
								Total compensation cost recognized in the income statement for stock-based employee and directors’ compensation awards was $457,500 and $1,280,679 in 2013 and 2012, respectively.
								The cost of all share-based awards to employees, including grants of warrants and restricted stock, is recognized in the financial statements based on the fair value of the awards at grant date. The fair value of the warrant award is determined using the Black-Scholes valuation model on the date of grant. The fair value of the share-based awards is recognized as stock-based compensation expense on a straight-line basis over the requisite service period from the date of grant. As of December 31, 2013, there was approximately $43,125 of total unrecognized compensation cost related to non-vested warrant based compensation arrangements granted under the Company’s compensation plan. The cost is expected to be recognized over a period of 2 years. This expected cost does not include the impact of any future stock-based compensation awards.
								In 2012 the Company issued 3,000,000 warrants to an officer. The Company valued the warrants utilizing the Black Scholes method with the following inputs: stock price of $0.10, exercise price of $0.10, volatility of 177.45%, term of 5 years, risk free rate of 2.50% and dividend rate of 0%.

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	13. COMMITMENTS AND CONTINGENCIES
	The Company entered into a license agreement with minimum royalty payments totaling $ 1,800,000 , $ 2,100,000 , $ 2,700,000 , $ 3,200,000 and $ 3,800,000 for each of the years ended 2014, 2015, 2016, 2017 and 2018, respectively. $ 900,000 was paid as of March 31, 2014 and recorded in prepaid expenses.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
DEBT	'
	8. DEBT
	Debt is as follows:
		December 31,
		2013		2012
	Promissory note dated December 17, 2002, issued to an accredited investor, maturing September 28, 2003, bearing interest at the rate of 10% per annum. The note is now due on demand. The holder of the note is entitled to convert all or a portion of the principal and interest at any time after the maturity date into shares of common stock of the Company at a price equal to $8.00/share of the principal. The note was paid off in September 2013.	$	-	$	25,000
	Convertible Promissory Note to an accredited investor dated May 20, 2003, maturing May 20, 2004, now due on demand, bearing interest at a rate 8% per annum payable in restricted shares of common stock. The Note is convertible at the option of the holder into common stock at the rate of $20.00 per share.		30,000		30,000
	One demand loan extended by an investor in March 2004 and January 2005, bearing interest at 12% per year, now due on demand. Principal in the amount of $5,000 was paid in September 2013.		10,000		15,000
	One promissory note issued to an accredited investors in May 2006, originally maturing in June 2006, due on demand. The note carried interest at the rate of 10% per year and is convertible into common shares at the rate of $20.00 /share. The note was acquired by a new investor and a new note was issued for the principal and accrued interest in August 2013.		-		25,000
	Two promissory notes issued to three accredited investors in September 2006, maturing at various dates between November 30, 2006 and January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		48,000		48,000
	One note was converted as of September 2, 2011 into common stock at the conversion price of $0.352 per share.
	Two promissory notes issued to three accredited investors in October 2006, maturing on January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share. One note was converted as of September 2, 2011 into common stock at the conversion price of $0.352 per share.		44,000		44,000
	One promissory note issued to an accredited investors in January 2007, maturing on March 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		75,000		75,000
	One promissory note issued to an accredited investor in May 2007, maturing on September 30, 2007, now due on demand. The note carried interest at the rate of 10% per year until maturity and thereafter is subject to a rate of 12% per year. The note calls for the interest payable in common stock, calculated at $8.00 per share. The note is convertible into common shares at the rate of $8.00 /share.		25,000		25,000
	Promissory note, originally in the amount of $2,710,563 issued to a service provider, due on July 31, 2008. The note carried interest at the rate of 10% per year compounded monthly. In November 2009, the creditor and the Company entered into an agreement whereby, against payment of $110,000 in cash, the principal amount of the note was reduced to $400,000.		400,000		400,000
	Two promissory notes, issued in November 2009 as part of a series of debt restructuring transactions whereby existing promissory notes, most of which were past due or payable on demand, and interest accrued thereon were exchanged into Units at the rate of 1 :1 between old note principal plus accrued interest to Unit price, at a price of $100,000 per Unit. Each Unit consisted of a 30 month promissory note for $100,000, carrying interest at 15% per year and 100 shares of Series F Convertible Preferred Stock, whereby every “F” share was converted into 120,000 common shares on April 20, 2010. The notes and interest accrued thereon are repayable in five quarterly installments beginning 18 months after issue. Six of the notes converted in September 2011 into Series G Convertible Preferred Stock at the rate of one share of G Preferred per $73.50 of principal and accrued interest. The Unit Note holders were entitled to a reduced conversion rate of one share of Series G Preferred per $50 of debt if they invested an amount equal to 25% of the principal amount of such holder’s Unit Note in the Series G Preferred equity offering. In April 2013, $67,021 of principal plus accrued interest was converted into 2,044 shares of Series G Preferred Stock, realizing a gain of $46,978.		85,726		152,747
	One promissory note issued to an accredited investor in March 2012, maturing September 23, 2013. The note carries interest at the rate of 10% per year until maturity and is payable quarterly in common stock valued at $0.20 per share. The note is convertible into common shares at the rate of $0.20 share. The note plus accrued interest was paid off in September 2013.		-		25,000
	Four promissory notes issued to an accredited investor in June and July 2012, maturing eight months after issuance. The notes carry interest at the rate of 24% per year. The notes and accrued interest were repaid in January 2013.		-		100,000
	One promissory note issued to an accredited investor in November 2012, maturing three months after issuance. The note carries interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		100,022
	One promissory note issued to an accredited investor in December 2012, maturing one month after issuance. The note carries interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		50,000
	One promissory note was issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The note is convertible into Series G Preferred Stock. The note bears interest at 10% per year and matures on March 31, 2015.		29,606		29,606
	Five promissory notes issued to accredited investors in March and April 2012, maturing thirty-six months after issuance. The note carries interest at the rate of 10% per year until maturity and are payable quarterly in common stock valued at $0.20 per share. The notes are convertible into common shares at the rate of $0.20 share. One note in the principal amount of $25,000 was paid off in January 2013.		74,306		39,584
	Two promissory notes issued to an accredited investor in March 2013, maturing twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes are convertible into common shares at the rate of $0.25/ share.		97,924		-
	Four notes issued to an accredited investor in April, May and June 2013, maturing between eight to twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes and accrued interest were repaid in January 2014.		191,551		-
	One promissory note issued to an accredited investor in May 2013, maturing ten months after issuance. The note carries interest at the rate of 15% per year until maturity. The note is convertible into common shares at the rate of $0.20/ share.		96,012		-
	One promissory note issued to an accredited investor in May 2013, maturing nine months after issuance. The note carries interest at the rate of 15% per year until maturity. The note and accrued interest was repaid in February 2014.		95,948		-
	One promissory note re-issued to an accredited investor in August 2013, maturing seven months after re-issuance. The note carries interest at the rate of 10% per year until maturity. The note and accrued interest was repaid in January 2014.		53,000		-
	One promissory note issued to an accredited investor in August 2013, maturing six months after issuance. The note carries interest at the rate of 15% per year until maturity.		24,197		-
	Total Debt		1,380,270		1,183,959
	Less short-term portion		1,276,358		1,144,375
	Long-term portion	$	103,912	$	39,584
	Included in total debt as of December 31, 2013 and 2012 of $1,380,270 and $1,183,959 is an unamortized debt discount of $70,062 and $135,417, respectively.
	Debt to affiliates is as follows:
		December 31,
		2013		2012
	Promissory note issued to an accredited investor in March 2009. The note was due on September 26, 2009 and carrying interest at 24% per year.	$	33,000	$	33,000
	Promissory note issued to an accredited investor in July 2009. The note was due on October 28, 2009 and carrying interest at 36% per year.		16,600		16,600
	Purchase order financing note issued in May 2010, carry interest at 24% per year and due on demand.		100,000		100,000
	One demand promissory note issued to an accredited investor in March 2012. The note carries interest at the rate of 12% per year and is payable quarterly in common stock valued at $0.20 per share. The note is convertible into common shares at the rate of $0.20 share. The note and accrued interest were repaid in January 2013.		-		75,000
	Eight promissory notes issued to accredited investors in June through September 2012, maturing eight months after issuance. The notes carry interest at the rate of 24% per year. The notes and accrued interest were repaid in January 2013.		-		264,000
	One promissory note issued to an accredited investor in October 2012 maturing four months after issuance. The notes carry interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		500,000
	Two promissory notes issued to accredited investors in December 2012 maturing one month after issuance. The notes carry interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		27,500
	Long-Term Debt to affiliates is as follows:
		December 31,
		2013		2012
	Four promissory notes were issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The notes are convertible into common shares at a rate of $0.20/share. The notes bear interest at 10% per year and mature on March 31, 2015.	$	1,425,522	$	1,425,522
	Eight promissory notes issued to accredited investors in May through August 2013, maturing six to nine months after issuance. The notes carry interest at the rate of 15% per year.		2,104,584		-
	Four promissory notes issued to accredited investors in July 2013, maturing seven months after issuance. The notes carry interest at the rate of 12% per year.		589,544		-
	Total debt to affiliates		4,269,250		2,441,622
	Less short-term portion due to affiliates		2,843,728		2,441,622
	Total Long-Term Debt to affiliates	$	1,425,522	$	-
	Included in total debt as of December 31, 2013 and 2012 of $4,269,250 and $2,441,622 is an unamortized debt discount of $82,560 and $0, respectively.
	The following is a schedule of future minimum debt payments as of December 31, 2013:
	Year Ending December 31,
	2014	$	4,269,250
	2015		1,380,270
	Total minimum payments required	$	5,649,520
	During 2012, the Company issued convertible debt with a carrying value of $391,000. The convertible debt included warrants and derivatives valued at approximately $1,100,000. The Company recorded a debt discount of $391,000 and a loss from warrants/derivative issued with debt greater than debt carrying value totaling $736,000.
	2013 Modification of Debt
	The following debt instruments were modified in 2013. The modification of debt included the addition of a conversion feature therefore requiring the Company to record the transaction in accordance with ASC 470 “Debt” modification of debt accounting.
	At December 31, 2013, the Company had promissory notes issued to four affiliated investors with an outstanding balance of $1,455,128, which were due on demand. As of December 31, 2013, the Company reached an agreement with the investors to extend the debt for fifteen months. At the date of extension, the debt payable was $1,455,128.  The fair value of the new debt is $1,096,487, which includes the fair value of the conversion feature of $358,641.  The conversion rate on the new convertible note is $0.20 per share of common stock.  As of December 31, 2013 the loss on debt modification of $358,641 has been included in the accompanying Statement of Stockholders’ Deficit.

INCOME_TAX

INCOME TAX	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
INCOME TAX	'
	9. INCOME TAX
	The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. The Company does not believe it has any tax positions that should not be recognized under FASB ASC 740-10.
	The reconciliation of the effective income tax rate to the Federal statutory rate is as follows:
			2013			2012
	Federal Income Tax Rate		-34	%		-34	%
	State Income Tax, Net of Federal Benefit		-5.94	%		-5.94	%
	Change in valuation allowance		39.94	%		39.94	%
	Sale of New Jersey NOL		-46	%		-34	%
	Effective Income Tax Rate		-46	%		-34	%
	As of December 31, 2013, the Company has net operating loss carry forwards of approximately $57,000,000 that can be utilized to offset future taxable income for Federal income tax purposes through 2031. Net operating loss carry forwards expire starting in 2024 through 2032. Utilization of these net loss carry forwards is subject to the limitations of Internal Revenue Code Section 382.  Because of the current uncertainty of realizing the benefit of the tax carry forward, a valuation allowance equal to the tax benefit for deferred taxes has been established.
	Deferred income taxes are recognized for the tax consequence of such temporary differences at the enacted tax rate expected to be in effect when the differences reverse. Because of the current uncertainty of realizing the benefit of the tax carry forward, a valuation allowance equal to the tax benefit for deferred taxes has been established. The full realization of the tax benefit associated with the carry forward depends predominantly upon the Company's ability to generate taxable income during the carry forward period.
	Significant components of the Company's deferred tax assets and liabilities are summarized as follows:
		December 31,
		2013			2012
	Deferred tax assets		23,165,000			21,190,000
	Less: Valuation Allowance		-23,165,000			-21,190,000
	Net Deferred Tax Assets	$	-		$	-
	The Company’s deferred income tax valuation allowance increased by $1,975,000 to $23,165,000 as of December 31 2013.

CAPITAL_STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2013
Stockholders Equity Note [Abstract]	'
CAPITAL STOCK	'
	10. CAPITAL STOCK
		a)	Series B, C, D Convertible Preferred Stock and Common Stock
			Convertible Series B preferred shares ("Series B") are non-dividend bearing, and are convertible into shares of the Company’s common stock at any time at the option of the holder and are subject to adjustment in accordance with certain anti-dilution clauses. Cumulative Series C preferred shares ("Series C") are not convertible but are entitled to cumulative cash dividends at the rate of $.65 per share per annum, payable in each year commencing the year after all the shares of Series B are retired. There were no cumulative cash dividends payable as of December 31, 2013 and 2012, respectively. Convertible Series D preferred shares ("Series D") are non-dividend bearing and are convertible into shares of the Company’s common stock at the option of the Company and are subject to adjustment in accordance with certain anti-dilution clauses. All Series D Preferred Shares were converted into common stock in April 2002.
		a.1)	Voting Rights
			The holders of Series B and Series C preferred stock have no voting rights. Each share of common stock is entitled to one vote.
		a.2)	Dividend Restrictions
			No cash dividends may be declared or paid on the Company’s common stock if, and as long as, Series B preferred stock is still outstanding or there are dividends in arrears on outstanding shares of Series C preferred stock. No dividends may be declared on Series C shares if, and as long as, any Series B shares are outstanding. There were no cumulative cash dividends payable as of December 31, 2013 and 2012, respectively.
		a.3)	Other information is summarized as follows:
			Convertible		Cumulative
			Series B		Series C
	Number of common shares to be issued upon conversion of each preferred share			10		None
	Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)		$	2	$	10	-1
	(1) Plus any dividend in arrears.
	b) Series E Convertible Preferred Stock
	b.1) Authorized Number
	Fifty Thousand (50,000) of the authorized shares of Preferred Stock are hereby designated “Series E Convertible Preferred Stock” par value $1.00 per share (“E Preferred”).
	b.2) Designation
	The rights, preferences, privileges, restrictions and other matters relating to E Preferred, as filed with the Secretary of State, Delaware, are as follows:
	(1)            Dividends   The shares of E Preferred shall not bear any dividends.
	(2)            Distribution of Assets Upon Liquidation   In the event the Company shall be liquidated, dissolved or wound up, whether voluntarily or involuntarily, each holder of shares of E Preferred, shall be able to share ratably in the proceeds available along with the holders of shares of Common Stock on an as converted basis (meaning for these purposes, that each share of E Preferred shall have rights equivalent to the number of shares of Common Stock into which such E Preferred is convertible).
	(3)            Voting Rights   Each holder of outstanding shares of E Preferred shall be entitled to the number of votes equal to the number of whole shares of Common Stock into which the share of E Preferred held by such holder would then be convertible assuming a sufficient number of shares of Common Stock were then authorized and available for issuance, at each meeting of the stockholders of the Company (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Company for their action or consideration (including without limitation, any matter voted on together with the holders of Common Stock).  Except as provided by law, by any of the provisions contained herein or by the provisions establishing any other series of stock, holders of E Preferred shall vote together with the holders of Common Stock as a single class.
	(4)            Mandatory Conversion of E Preferred      All of the shares of E Preferred shall be automatically converted into shares of Common Stock at the Conversion Rate then in effect (a "Mandatory Conversion").  The “Conversion Rate” is 10,000 shares of Common Stock for each share of E Preferred. All issued and outstanding shares of E Preferred converted into shares of common stock on March 15, 2010 at the rate of 10,000 shares of common stock for each share of E Preferred.
	c) Series F Convertible Preferred Stock
	c.1) Authorized Number
	Ten Thousand (10,000) of the authorized shares of Preferred Stock are hereby designated “Series F Convertible Preferred Stock” par value $1.00 per share (“F Preferred”).
	c.2) Designation
	The rights, preferences, privileges, restrictions and other matters relating to F Preferred, as filed with the Secretary of State, Delaware, are as follows:
	(1)            Dividends   The shares of F Preferred shall not bear any dividends.
	(2)            Distribution of Assets Upon Liquidation   In the event the Company shall be liquidated, dissolved or wound up, whether voluntarily or involuntarily, each holder of shares of F Preferred, shall be able to share ratably in the proceeds available along with the holders of shares of Common Stock on an as converted basis (meaning for these purposes, that each share of F Preferred shall have rights equivalent to the number of shares of Common Stock into which such F Preferred is convertible).
	(3)            Voting Rights   (a)  Each holder of outstanding shares of F Preferred shall be entitled to the number of votes equal to the number of whole shares of Common Stock into which the share of F Preferred held by such holder would then be convertible assuming a sufficient number of shares of Common Stock were then authorized and available for issuance, at each meeting of the stockholders of the Company (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Company for their action or consideration (including without limitation, any matter voted on together with the holders of Common Stock).  Except as provided by law, by any of the provisions contained herein or by the provisions establishing any other series of stock, holders of F Preferred shall vote together with the holders of Common Stock as a single class.
	(b)  Until such time as the Company has achieved annual EBITDA (as defined in the agreement) of at least $10,000,000, the consent of a majority of the holders of the outstanding shares of F Preferred, voting as a separate class, shall be required to approve: (i) any offer, sale, designation or issuance of any security senior to or pari passu with the F Preferred; (ii) the repurchase or redemption of capital stock of the Company (except from employees at cost upon termination); (iii) any increase or decrease in the number of authorized shares of Common Stock or Preferred Stock; (iv) any amendment to the Certificate of Incorporation or other governing documents of the Company; (v) any alteration or change to the rights, preferences or privileges of the F Preferred, by merger, consolidation or otherwise; (vi) the entry into the sale or exclusive license of all or substantially all the assets of the Company, mergers, consolidations, other business combinations, recapitalizations and liquidations; (vii) any acquisition of the stock or assets of any other entity; (viii) any dividends or distributions on the Company’s capital stock;  and (ix) the expansion into any new businesses.  The foregoing will apply to any subsidiary or controlled affiliate of the Company.
	(4)            Conversion of F Preferred   At the option of the holder each share of F Preferred may be converted into fully paid and non-assessable shares of the Company’s Common Stock at the rate of 120,000 shares of Common Stock for each share of F Preferred.
	d) Series G Convertible Preferred Stock
	c.1) Authorized Number
	Four Hundred Thousand (400,000) of the authorized shares of Preferred Stock are hereby designated “Series G Convertible Preferred Stock” par value $1.00 per share, stated value $50 (“G Preferred”).
	c.2) Designation
	The rights, preferences, privileges, restrictions and other matters relating to G Preferred, as filed with the Secretary of State, Delaware, are as follows:
	(1)            Dividends   The shares of G Preferred shall bear a 10% annual dividend, payable quarterly in kind based on the equivalent of 90% of the average of the last ten trading day closing price of the Common Stock prior to the dividend payment date.
	(2)            Distribution of Assets Upon Liquidation   In the event the Company shall be liquidated, dissolved or wound up, whether voluntarily or involuntarily, each holder of shares of G Preferred, has a liquidation preference before any payment or distribution on the Common Stock or on any other class of stock ranking junior to the G Preferred up to the Stated Value and, thereafter, shares ratably in proceeds available along with the holders of shares of Common Stock and any other share of stock entitled to payment upon liquidation.
	(3)            Voting Rights   (a)  Each holder of outstanding shares of G Preferred shall be entitled to the number of votes equal to the number of whole shares of Common Stock into which the share of G Preferred held by such holder would then be convertible assuming a sufficient number of shares of Common Stock were then authorized and available for issuance, at each meeting of the stockholders of the Company (and written actions of stockholders in lieu of meetings) with respect to any and all matters presented to the stockholders of the Company for their action or consideration (including without limitation, any matter voted on together with the holders of Common Stock).  Except as provided by law, by any of the provisions contained herein or by the provisions establishing any other series of stock, holders of G Preferred shall vote together with the holders of Common Stock as a single class.
	(4)            Conversion of G Preferred   At the option of the holder each share of G Preferred may be converted into fully paid and non-assessable shares of the Company’s Common Stock at the rate of 250 shares of Common Stock for each share of G Preferred. The holder of each G Preferred has anti-dilution rights whereby any Common Stock shares that are issued or sold at a price less than the Conversion Rate in effect, then the Conversion Rate shall be reduced to an amount equal to the New Securities Issuance Price.
	e) Common Stock
	e.1) Authorized Number
	Two Billion (2,000,000,000) of the authorized shares of Common Stock are hereby designated “ Common Stock” par value $0.001 per share.
	The cost of all share-based awards to employees, including grants of warrants and restricted stock, is recognized in the financial statements based on the fair value of the awards at grant date. The fair value of the warrant award is determined using the Black-Scholes valuation model on the date of grant. The fair value of the share-based awards is recognized as stock-based compensation expense on a straight-line basis over the requisite service period from the date of grant. As of December 31, 2013, there was approximately $43,125 of total unrecognized compensation cost related to non-vested warrant based compensation arrangements granted under the Company’s compensation plan. The cost is expected to be recognized over a period of 2 years. This expected cost does not include the impact of any future stock-based compensation awards.

OPERATING_LEASE_LICENSE_AND_EM

OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS	12 Months Ended
	Dec. 31, 2013
Operating Lease And License And Employment Commitments [Abstract]	'
OPERATING LEASE AND LICENSE AND EMPLOYMENT COMMITMENTS	'
		12	OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS
	The Company leases office space in Newark, NJ under an operating lease.
	The following is a schedule of future minimum rental payments (exclusive of allocated expenses) required under operating leases that have initial or non-cancelable lease terms in excess of one year as of December 31, 2013:
	Year Ending December 31,
	2014		$	50,400
	2015			50,400
	2016			12,600
	Total minimum payments required		$	113,400
	Rent expense for the Company under operating leases for the years ended December 31, 2013 and 2012 was $47,282 and $37,928, respectively.
	The Company entered into a license agreement with minimum royalty payments totaling $13,600,000. In the year ended December 31, 2013, $450,000 has been paid for the year ending December 31, 21014.
	Year Ending December 31,
	2014		$	1,800,000
	2015			2,100,000
	2016			2,700,000
	2017			3,200,000
	2018			3,800,000
			$	13,600,000
	Pursuant to the Summary of Debt Reorganization and Financing dated July 14, 2011, Mr. James salary was amended to reduce his salary to $150,000 per annum until the Company reaches three consecutive fiscal quarters of positive Net Income at which point his annual salary will increase to $200,000. The gross-up provisions with regards to any issuances under the Management Warrant Grant Program have been eliminated. Mr. James will receive a bonus of $25,000 upon receiving three consecutive fiscal quarters of positive Net Income.
	Pursuant to an amended and restated employment agreement, Carl Germano is employed as the Chief Science Officer of Millennium. The Agreement terminates on November 1, 2014; provided, Mr. Germano has the right to extend the term of employment for two additional years.  Pursuant to the Agreement, Mr. Germano currently receives a base annual salary of $150,000 per year which increases to $200,000 per year in the event (a) the Company's annual revenues exceed $15,000,000; (b) the Company enters into a licensing agreement with an unrelated third party where the minimum upfront licensing fee is no less than $3,000,000; or (c) the Company achieves two quarters of positive cash flow.  In addition, during the term of the Agreement, Mr. Germano is entitled to receive an annual bonus at the discretion of the Company. Mr. Germano also received 114.1667 E Preferred (which in 2010 converted into 18,021 shares of Common Stock) and Performance Shares.
	The Agreement terminates upon Mr. Germano’s death and may be terminated at the option of the Company as a result of Mr. Germano’s disability or for “cause” as defined in the Agreement.  Mr. Germano has the right to terminate the Agreement for “good reason” as defined in the Agreement.  In the event that the Agreement is terminated due to Mr. Germano’s death or disability, he is entitled to receive his annual salary for a period equal to the lessor of (i) three months from the date of death or disability or (ii) the balance of the Term; and all other accrued but unpaid compensation and benefits.  If the Agreement is terminated by the Company for “cause”, Mr. Germano is not entitled to receive any compensation other than accrued but unpaid compensation and benefits.  In the event Mr. Germano terminates the Agreement for “good reason”, the Company shall pay to Mr. Germano his annual salary through the date of the end of the contract term; bonuses that have accrued and are unpaid as of the date of termination; and any Options which have been granted to Mr. Germano as of the date of the termination.  The Agreement also provides for Mr. Germano is subject to confidentiality, non-solicitation and non-compete covenants for a period of one year following his termination, provided such termination is not by the Company without “cause” or by Mr. Germano for “good reason”.

STOCK_GRANTED_FOR_SERVICES_AND

STOCK GRANTED FOR SERVICES AND FINANCING	12 Months Ended
	Dec. 31, 2013
Stock Based Compensation Disclosure [Abstract]	'
STOCK GRANTED FOR SERVICES	'
		13	STOCK GRANTED FOR SERVICES AND FINANCING
	During the year ended December 31, 2013 the Company issued 1,637,500 shares of Common Stock valued at $202,270 and 4,000 shares of Convertible Series G Preferred Stock valued at $122,000 for services.The value of the Common Stock is the fair market value on the date of issuance.
	During the year ended December 31, 2013 the Company issued 6,390,625 shares of Common Stock valued at $505,509 for compensation. The value of the Common Stock is the fair market value on the date of issuance.

RELATED_PARTY_TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Dec. 31, 2013
Related Party Transactions [Abstract]	'
RELATED PARTY TRANSACTIONS	'
	14. RELATED PARTY TRANSACTIONS
	During 2013 and 2012, we also issued restricted stock awards and warrants to certain officers and directors, as follows:
	Mr. James received 2,000,000 shares of common stock in January 2013 valued at $150,200, in recognition of services performed. The value of the Common Stock is the fair market value on the date of issuance.
	Mr. Germano received 2,000,000 shares of common stock in January 2013 valued at $150,200, in recognition of services performed. The value of the Common Stock is the fair market value on the date of issuance.
	Mr. DeLucia received 500,000 shares of common stock in January 2012 valued at $50,000, for director fees. The value of the Common Stock is the fair market value on the date of issuance.
	In 2012 the Company issued 3,000,000 warrants to an officer. The Company valued the warrants utilizing the Black Scholes method with the following inputs: stock price of $0.10, exercise price of $0.10, volatility of 177.45%, term of 5 years, risk free rate of 2.50% and dividend rate of 0%.
	Refer to footnote 8 for affiliated debt transactions.

LITIGATION

LITIGATION	12 Months Ended
	Dec. 31, 2013
Litigation Settlements [Abstract]	'
LITIGATION	'
	15. LITIGATION
	All legal matters contained within this Note to the Financial Statement have been accrued for on the Company’s balance sheet as a liability as of December 31, 2013.
	Creative Healthcare Solutions, LLC vs. Millennium Biotechnologies Inc, Ct. of Common Pleas of Delaware County Ohio, Case No. 07 CV H 11 1420)  Millennium was not satisfied with the service rendered by Creative Healthcare Solutions, LLC in 2005 which were associated with the development of Resurgex Select collateral materials developed in December of 2005.  Millennium subsequently was forced to destroy and dispose of over 80% of the materials provided by Creative Healthcare Solutions due to the poor quality of the materials.  Millennium has been unsuccessful in resolving the dispute and subsequently Creative Healthcare Solutions, LLC has filed legal action for demand of payment in the amount of $63,718 for services rendered.  Millennium continues to negotiate a settlement with regards to this legal proceeding.
	Robert Half International vs. Millennium Biotechnologies, Inc. filed on September 30, 2009 in the Superior Court of New Jersey, Law Division, Middlesex County.  Robert Half International claims a total of $18,507 plus costs and fees based upon the Millennium Biotechnologies, Inc.’s failure to pay the plaintiff the fees associated with the full time hiring of an employee.

SUBSEQUENT_EVENTS

SUBSEQUENT EVENTS	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Subsequent Events [Abstract]	'	'
SUBSEQUENT EVENTS	'	'
	14. SUBSEQUENT EVENTS	16. SUBSEQUENT EVENTS
	During the second quarter of 2014 the Company issued to Seahorse Enterprises, LLC notes in the amount of $785,000 that bear interest at the annual rate of 12%. The notes matures nine months from the funding of the notes.	The Company received $3,357,144 on January 23, 2014 from the sale of the New Jersey Technology Business Tax Transfer Program. The Company paid a fee of $302,143 upon the successful receipt of the sale proceeds. The net amount the Company received was $3,055,001.
	During the second quarter of 2014 the Company issued to an officer and entity controlled by the officer notes in the amount of $200,000 that bear interest at the annual rate of 12%. The notes matures nine months from the funding of the notes.	In January 2014 the Company approved issuance of 10,000 shares of Series G preferred associated with the one year extension of a $2,000,000 loan.
	During the second quarter of 2014 the Company issued to an accredited investor notes in the amount of $100,000 that bear interest at the annual rate of 15%. The notes matures eighteen months from the funding of the notes. The investor also will receive 125,000 shares of common stock.	In January 2014 the Company paid off $528,000 of principal for notes that were outstanding as of December 31, 2013.
	During the second quarter of 2014 the Company issued to an accredited investor notes in the amount of $110,000. The notes matures December 1, 2014.	In February 2014 the Company increased the preferred stock, convertible Series G authorized shares to 400,000.
	During the third quarter of 2013 the Company received $1,000,000 net proceeds and issued a 12% secured subordinated convertible promissory note to the Investor in the principal amount of $1,500,000 (the “Note”) and a Common Stock Purchase Warrant (the “Warrant”) to purchase 2,500,000 shares of the Company’s Common Stock (the “Common Stock”). Principal and interest (at the rate of 12% per annum) is due and payable under the Note on July 14, 2015. If the Company files a registration statement with the Securities and Exchange Commission (the “SEC”) covering the resale of the shares of Common Stock issuable upon conversion of the Note and exercise of the Warrant on or before 45 days after July 14, 2014, the principal amount of the Note shall be reduced by $200,000, and if the registration statement is declared effective by the SEC within 120 days of July 14, 2014, the principal amount of the Notes shall be further reduced by $300,000. Principal and accrued but unpaid interest is convertible into shares of the Company’s Common Stock at a price (the “Conversion Price”) equal the lesser (i) $0.35 per share, or (ii) 62% of the lowest trading price of the Common Stock as quoted by Bloomberg L.P. for the ten trading days immediately preceding the date of conversion (subject to adjustments as provided in the Note). However, in no event shall the Conversion Price be less than $0.031 per share.	In March 2014 the Company approved issuance of 4,750,000 shares of common stock to certain officers and employees.
		In March 2014 the Company approved issuance of 500,000 shares of common stock for director fees.

SUMMARY_OF_SIGNIFICANT_ACCOUNT1

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]	'	'
Organization	'	'
	Organization	Organization and business
	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the Company or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., is a holding company for its subsidiary Millennium Biotechnologies, Inc. ("Millennium").	On March 15, 2010 the Company changed its name to Inergetics, Inc. Inergetics, Inc. (the “Company” or "Inergetics"), formerly Millennium Biotechnologies Group, Inc., which is the holding company for its subsidiary Millennium Biotechnologies, Inc. (the “Subsidiary” or "Millennium").
	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey.  Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science.  Millennium’s principal source of revenue is from sales of its nutraceutical supplements, Resurgex Select® and Resurgex Essential™ and Resurgex Essential Plus™ which serve as a nutritional support for immuno-compromised individuals undergoing medical treatment for chronic debilitating diseases. Millennium has developed Surgex for the sport nutritional market. The Company acquired Bikini Ready®, a leader in weight loss lifestyle solutions and SlimTrim™, the affordable, premium value diet brand. The Company has a licensing agreement to sell the Martha Stewart Essentials line of supplements.   The Company’s efforts going forward will focus on sales of Martha Stewart Essentials™ line of supplements, Surgex in powder and pill forms as well as powder and pills for Bikini Ready and pills for SlimTrim.	Millennium was incorporated in the State of Delaware on November 9, 2000 and is located in New Jersey. Millennium is a research based bio-nutraceutical corporation involved in the field of nutritional science. Millennium’s principal source of revenue is from sales of its nutraceutical supplements.
	The accompanying unaudited condensed consolidated financial statements include the accounts of Inergetics, Inc. and its subsidiary. These condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Certain information in footnote disclosures normally included in financial statements prepared in conformity with accounting principles generally accepted in the United States of America has been condensed or omitted pursuant to such principles and the financial results for the periods presented may not be indicative of the full year’s results. The Company believes that the disclosures are adequate to make the information presented not misleading. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. These condensed consolidated financial statements should be read in conjunction with the December 31, 2013 audited financial statements and the accompanying notes thereto filed with the Securities and Exchange Commission on Form 10-K.
Reclassifications	'	'
		Reclassifications
		Certain reclassifications have been made to the 2012 financial statements to conform to the consolidated 2013 financial statement presentation. These reclassifications had no effect on net losses or cash flows as previously reported.
Principles of Consolidation	'	'
	Principles of Consolidation	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of the Company and its subsidiary.  All significant inter-company transactions and balances have been eliminated.	The consolidated financial statements include the accounts of the Company and its subsidiary. All significant inter-company transactions and balances have been eliminated in consolidation.
Use of Estimates	'	'
	Use of Estimates	Use of Estimates
	The preparation of the financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.	The preparation of the financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates and judgments on our experience and on various assumptions we believe are reasonable under the circumstances. Actual results may differ from these estimates under different assumptions.
Cash and Cash Equivalents	'	'
		Cash and Cash Equivalents
		Cash and all highly liquid investments with a maturity of three months or less from the date of purchase, including money market mutual funds, short-term time deposits, and government agency and corporate obligations, are classified as cash and cash equivalents.
Accounts Receivable	'	'
		Accounts Receivable
		The Company continuously monitors collections and payments from our customers and regularly adjusts credit limits of customers based upon payment history and a customer’s current credit worthiness, as judged by us. There was no allowance for doubtful accounts as of December 31, 2013 and 2012.
Receivable from Technology Business Tax Certificate Transfer Program	'	'
		Receivable from Technology Business Tax Certificate Transfer Program
		The receivable is from the Company selling the New Jersey State net operating loss carry forwards. The Company was able to transfer $3,357,144 of total available tax benefits of $3,357,144 for the year ended December 31, 2013. The receivable was collected on January 23, 2014. The Company was able to transfer $2,209,715 of total available tax benefits of $5,187,471 for the year ended December 31, 2012. The receivable was collected on January 14, 2013. The Company paid a fee of $302,143 and $198,875 for the years ended December 31, 2013 and 2012, respectively, in connection with the approval of the Tax Certificate Transfer Program.
Goodwill	'	'
	Goodwill	Goodwill
	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment.	Goodwill and other acquired intangible assets with indefinite lives are not amortized, but are tested for impairment annually and when an event occurs or circumstances change such that it is more likely than not that an impairment may exist. Our annual testing date is December 31. We test goodwill for impairment by first comparing the carrying value of net assets to the fair value of the related operations. If the fair value is determined to be less than carrying value, a second step is performed to compute the amount of the impairment. In this process, a fair value for goodwill is estimated, based in part on the fair value of the operations, and is compared to its carrying value. The shortfall of the fair value below carrying value represents the amount of goodwill impairment. Intangibles consist of brand and trade names acquired in business combinations. We test these intangibles for impairment by comparing their carrying value to current projections of discounted cash flows attributable to the brand and trade names. Any excess carrying value over the amount of discounted cash flows represents the amount of the impairment. At the conclusion of our test the Company has realized that there has not been any impairment.
Property and Equipment	'	'
		Property and Equipment
		Property and equipment are stated at cost less accumulated depreciation. Depreciation, which includes amortization of assets under capital leases, is calculated using the straight-line method over the estimated useful lives of the assets: 3-8 years for machinery and equipment, leasehold improvements are amortized over the shorter of the estimated useful lives or the underlying lease term. Repairs and maintenance expenditures which do not extend the useful lives of related assets are expensed as incurred. As of December 31 2012 and 2013, all property and equipment has been fully depreciated.
Patents	'	'
		Patents
		Patents are capitalized and amortized over 240 months. Amortization expense was $1,551 and $576 for 2013 and 2012, respectively.
Evaluation of Long-Lived Assets	'	'
		Evaluation of Long-Lived Assets
		Long-lived assets are assessed for recoverability on an ongoing basis as impairment indicators arise. In evaluating the fair value and future benefits of long-lived assets, their carrying value would be reduced by the excess, if any, of the long-lived asset over management’s estimate of the anticipated undiscounted future net cash flows of the related long-lived asset.
Revenue Recognition	'	'
	Revenue Recognition	Revenue Recognition
	Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which occurs at shipping (F.O.B. terms).   Upon shipment to various customers when all performance obligations are met and collectability is reasonably assured revenue is recognized.   Upon shipment to specific customers with the right of return the Company defers revenues as returns are not reasonably estimable.   As of March 31, 2014 and December 31, 2013, deferred revenue totaled $1,010,178 and $1,268,470, respectively.	Revenue is recognized net of discounts, rebates, promotional adjustments, price adjustments and estimated returns and upon transfer of title and risk to the customer which generally occurs at shipping (F.O.B. terms). Upon shipment, the Company has no further performance obligations and collection is reasonably assured as the majority of sales are paid for prior to shipping.
	Deferred Revenue and Deferred Cost of Goods Sold	Discounts are reductions to invoiced amounts offered to customers for payment within a specified period and are estimated upon sale utilizing historic customer payment experience.
	Deferred revenue consists substantially of amounts billed or payments received in advance of revenue recognition. Deferred cost of goods sold as of March 31, 2014 and December 31, 2013 of $456,741 and $569,036, respectively, related to deferred product revenues includes direct product costs. Once all revenue recognition criteria have been met, the deferred revenues and associated cost of goods sold are recognized.	Consistent with industry practice, the Company maintains a return policy that allows customers to return product within a specified period prior and subsequent to the expiration date. The Company’s estimate of the provision for returns is generally based upon historic experience with actual returns.
		Price adjustments, which include shelf stock adjustments, are credits issued to reflect decreases in the selling prices of products. Shelf stock adjustments are based upon the amount of product which the customer has remaining in its inventory at the time of the price reduction. Decreases in selling prices are discretionary decisions made by the Company to reflect market conditions. Amounts recorded for estimated price adjustments are based upon specified terms with direct customers, estimated launch dates of competing products, estimated declines in market price and, in the case of shelf stock adjustments, estimates of inventory held by the customer.
		Certain retailers require guaranteed sales. Revenue is recognized as sales are made to the retail consumer.
Advertising costs	'	'
		Advertising costs
		Advertising costs are charged to operations when incurred. Advertising expense was $8,157 and $261 for the years ended December 31, 2013 and 2012, respectively.
Shipping and Handling Costs	'	'
		Shipping and Handling Costs
		Shipping costs of $43,299 and $8,065 are included in cost of sales for the years ended December 31, 2013 and 2012, respectively. Handling costs of $44,467 and $37,358 are included in general and administrative expenses for the years ended December 31, 2013 and 2012, respectively.
Stock and Warrant Based Compensation	'	'
		Stock and Warrant Based Compensation
		Stock and warrant based compensation is measured at the grant date, based on the calculated fair value of the award, and is recognized as an expense over the requisite employee service period (generally the vesting period of the grant). Compensation expense is recognized based on the estimated grant date fair value method using the Black-Scholes valuation model. The Company account for the issuance of stock and warrants for services based on the estimated fair value of options and warrants using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly based on the subjective assumptions used in the pricing model.
		We account for the issuance of stock and warrants for services from non-employees based on an estimate of the fair value of warrants issued using the Black-Scholes pricing model. This model’s calculations include the exercise price, the market price of shares on grant date, weighted average assumptions for risk-free interest rates, expected life of the warrant, expected volatility of our stock and expected dividend yield. The amounts recorded in the financial statements for share-based expense could vary significantly if we were to use different assumptions.
		The Company issued 1,140,000 warrants, that vest over four years, during the year ended December 31, 2013 for an expense of $206,700 and 7,500,000 warrants, that vested over three years, for an expense of $457,500 during the year ended December 31, 2012. The Company did not issue any stock options during the year ended December 31, 2013 and 2012, respectively.
Income Taxes	'	'
	Income Taxes	Income Taxes
	The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.	The Company provides for income taxes based on enacted tax law and statutory tax rates at which items of income and expenses are expected to be settled in the Company’s income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company has incurred net operating losses for financial-reporting and tax-reporting purposes. Accordingly, for Federal and state income tax purposes, the benefit for income taxes has been offset entirely by a valuation allowance against the related federal and state deferred tax assets for the years ended December 31, 2013 and 2012.
Loss Per Common Share	'	'
	Loss Per Common Share	Loss Per Common Share
	Net loss per share, in accordance with the provisions of ASC 260, “Earnings Per Share” is computed by dividing net loss by the weighted average number of shares of Common Stock outstanding during the period. Common Stock equivalents have not been included in this computation since the effect would be anti-dilutive. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock and convertible debt are not considered in the diluted income (loss) per share calculation since the effect would be anti-dilutive.	Basic and diluted loss per common share is computed by dividing net loss by the weighted average number of common shares outstanding during the periods. Potential common shares used in computing diluted earnings per share related to stock options, warrants, convertible preferred stock and convertible debt which, if exercised, would have an anti- dilutive effect on earnings per share, and there for have not been included Anti-dilutive securities not included in net loss per share calculations for the years presented include:
			December 31,
		Potentially dilutive securities:	2013		2012
		Convertible debt and accrued interest		10,751,345		10,775,363
		Liability of shares to be issued		3,330,000		2,300,000
		Convertible Preferred stock		49,713,545		37,929,545
		Outstanding time-based warrants		19,323,406		18,190,906
Fair Value of Financial Instruments	'	'
	Fair Value of Financial Instruments	Fair Value of Financial Instruments
	For financial instruments including cash, accounts receivable, prepaid expenses, debt, accounts payable and accrued expenses, the carrying values approximated their fair value.	The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The levels are defined as follows:
	Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.	Level 1 – quoted prices for identical instruments in active markets;
		Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and
		Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
		For financial instruments including cash, prepaid expenses and other current assets, short-term debt, accounts payable and accrued expenses, it was assumed that the carrying values approximated fair value because of their short-term maturities.
		Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial statement. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
Research and Development	'	'
		Research and Development
		Research and development costs are expensed as incurred.

SUMMARY_OF_SIGNIFICANT_ACCOUNT2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2013
Accounting Policies [Abstract]	'
Schedule of Weighted Average Number of Shares	'
	Anti-dilutive securities not included in net loss per share calculations for the years presented include:
		December 31,
	Potentially dilutive securities:	2013		2012
	Convertible debt and accrued interest		10,751,345		10,775,363
	Liability of shares to be issued		3,330,000		2,300,000
	Convertible Preferred stock		49,713,545		37,929,545
	Outstanding time-based warrants		19,323,406		18,190,906

BUSINESS_ACQUISITION_Tables

BUSINESS ACQUISITION (Tables)	3 Months Ended			12 Months Ended
	Mar. 31, 2014			Dec. 31, 2013
Business Combinations [Abstract]	'			'
BUSINESS ACQUISITION	'			'
	The Company’s allocation to identifiable intangible assets and liabilities according to their respective fair values, is as follows:			The Company’s allocation to identifiable intangible assets and liabilities according to their respective fair values, is as follows:
	Intangible assets, trademarks	$	100,000	Intangible assets, trademarks	$	100,000
	Intangible assets, customer list		5,000	Intangible assets, customer list		5,000
	Goodwill		135,000	Goodwill		135,000
	Purchase Price	$	240,000	Purchase Price	$	240,000

INVENTORIES_Tables

INVENTORIES (Tables)	3 Months Ended					12 Months Ended
	Mar. 31, 2014					Dec. 31, 2013
Disclosure - Inventories [Abstract]	'					'
Inventory	'					'
	Inventories consist of the following:					Inventories are stated at the lower of cost or market and consist of finished goods and packaging for the Company’s Surgex™, Bikini Ready™, SlimTrim and Martha Stewart™ Essentials product lines. Cost-of-goods sold are calculated using the weighted average costing method. Inventories consisted of the following:
		March 31,		December 31,			December 31,
		2014		2013			2013		2012
	Finished Goods	$	1,029,452	$	378,472	Finished Goods	$	378,472	$	2,344
	Packaging		58,054		41,714	Work-in-process		-		49,200
			1,087,506		420,186	Packaging		41,714		1,832
	Less: Reserve for obsolescence		-		-			420,186		53,376
	Total	$	1,087,506	$	420,186	Less: Reserve for obsolescence		-		-49,200
						Total	$	420,186	$	4,176

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	3 Months Ended					12 Months Ended
	Mar. 31, 2014					Dec. 31, 2013
Payables and Accruals [Abstract]	'					'
Accounts Payable and Accrued Liabilities	'					'
	Accounts payable and accrued expenses consisted of the following:					Accounts payable and accrued expenses consisted of the following:
		March 31,		December 31,			December 31,
		2014		2013			2013		2012
	Accounts payable	$	2,527,020	$	2,866,017	Accounts payable	$	2,866,017	$	1,224,313
	Owed to officer		5,650		16,088	Accrued interest		1,016,584		669,035
	Accrued interest		411,269		1,016,584	Accrued rent expense		135,874		135,874
	Accrued rent expense		135,874		135,874	Accrued salaries, bonuses and payroll taxes		824,492		612,712
	Accrued salaries, bonuses and payroll taxes		143,648		824,492	Accrued professional fees		230,433		204,247
	Accrued professional fees		196,976		230,433	Owed to officers		16,088		-
		$	3,420,437	$	5,089,488		$	5,089,488	$	2,846,181

SHORT_TERM_DEBT_NET_OF_DEBT_DI1

SHORT TERM DEBT, NET OF DEBT DISCOUNT (Tables)	3 Months Ended
	Mar. 31, 2014
Short-term Debt [Abstract]	'
Unsecured Notes, net debt discount	'
	Unsecured Notes, net debt discount, consist of the following:
		March 31,		December 31,
		2014		2013
	Unsecured Convertible Notes	$	1,261,867	$	1,450,333
	Debt discount		-72,512		-70,063
			1,189,355		1,380,270
	Less long term portion		151,098		1,276,358
	Short term portion	$	1,038,257	$	103,912

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	3 Months Ended									12 Months Ended
	Mar. 31, 2014									Dec. 31, 2013
Fair Value Disclosures [Abstract]	'									'
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques	'									'
	The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis									The following table represents the fair value hierarchy for those financial assets measured at fair value on a recurring basis:
		Fair Value at								December 31, 2013	Level I		Level II		Level III		Total
		March 31,		Fair Value Measurement Using
		2014		Level 1		Level 2		Level 3		Derivative liability						318,000		318,000
	Derivative liability – Conversion Feature	$	1,332,000		-		-	$	1,332,000	Total liabilities	$	-	$	-	$	318,000	$	318,000
		$	1,332,000		-		-	$	1,332,000
										December 31, 2012	Level I		Level II		Level III		Total
		Fair Value at
		December 31,		Fair Value Measurement Using						Derivative liability						227,000		227,000
		2013		Level 1		Level 2		Level 3		Total liabilities	$	-	$	-	$	227,000	$	227,000
	Derivative liability – Conversion Feature	$	318,000		-		-	$	318,000
		$	318,000		-		-	$	318,000
Liabilities measured at fair value on a recurring basis using significant unobservable inputs	'									'
	The table below sets forth a summary of changes in the fair value of the Company’s Level 3 financial liabilities (Derivative liability – Conversion Feature) for the three months ended March 31, 2014:									Liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level3):
		March 31,									Derivative
		2014									Liabilities
	Balance at December 31, 2013	$	318,000							1-Jan-13	$	-227,000
	Derivative converted into Equity		-8,000							Loss on fair market valuation of derivatives		-91,000
	Change in fair market value of Conversion Feature		1,022,000							31-Dec-13	$	-318,000
	Balance at March 31, 2014	$	1,332,000

WARRANTS_Tables

WARRANTS (Tables)	3 Months Ended							12 Months Ended
	Mar. 31, 2014							Dec. 31, 2013
Stock Warrants Disclosure [Abstract]	'							'
Warrant Activity	'							'
	Warrant activity for the three months ended March 31, 2014 is as follows:							Millennium had no options issued pursuant to this Plan as of December 31, 2013 and 2012, respectively.
			Weighted
			Average		Remaining	Aggregate				December 31, 2013							December 31, 2012
		Number of	Exercise		Contractual Term In	Intrinsic					Shares		Weighted				Shares		Weighted
		Warrants	Price		Months	Value							Average						Average
	Outstanding at December 31, 2013	19,323,406	$	0.2	63	$	300,000						Exercise						Exercise
													Price						Price
	Granted	-		-	55		-
								Warrants outstanding - beginning of year			18,190,906		$	0.225				7,631,544	$	0.404
	Exercised	-531,262		0.104	-		-	Warrants exercised			-			-				-		-
								Warrants granted			1,140,000			0.185				10,587,500		0.129
	Expired or cancelled	-		-	-		-	Warrants expired			-7,500			60				-28,138		12,446
	Outstanding and exercisable at March 31, 2014	18,792,144	$	0.197	Nov-92	$	1,878,967	Warrants outstanding - end of year			19,323,406		$	0.2				18,190,906	$	0.225
								Warrants price range at end of year		$0.10 - $16.00								$0.10 - $60.00
								Warrants price for exercised shares			$0.00							$0.00
Schedule of fixed-price stock options and warrants outstanding	'							'
								The following table summarizes information about fixed-price warrants outstandings
								Range of Exercise		Number		Average		Weighted		Number			Weighted
								Prices		Outstanding at		Remaining		Average		Exercisable at			Average
										December 31,		Contractual		Exercise Price		December 31,			Exercise Price
										2013		Life				2012
								$	0.1	7,500,000		47 Mo’s		$	0.1			7,500,000	$	0.1
								$	0.17	8,033,406		92 Mo’s		$	0.17			7,533,406	$	0.17
								$	0.2	3,727,500		16 Mo’s		$	0.2			3,087,500	$	0.2
								$	16	62,500		72 Mo’s		$	16			62,500	$	16
								$	60	-				$	60			7,500	$	60
										19,323,406								18,190,906

CAPITAL_STOCK_Tables

CAPITAL STOCK (Tables)	12 Months Ended
	Dec. 31, 2013
Stockholders Equity Note [Abstract]	'
Schedule of Capital Units	'
	Other information is summarized as follows:
		Convertible		Cumulative
		Series B		Series C
	Number of common shares to be issued upon conversion of each preferred share		10		None
	Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)	$	2	$	10	-1
	(1) Plus any dividend in arrears.

DEBT_Tables

DEBT (Tables)	12 Months Ended
	Dec. 31, 2013
Debt Disclosure [Abstract]	'
Schedule of debt to related parties	'
	Debt is as follows:
		December 31,
		2013		2012
	Promissory note dated December 17, 2002, issued to an accredited investor, maturing September 28, 2003, bearing interest at the rate of 10% per annum. The note is now due on demand. The holder of the note is entitled to convert all or a portion of the principal and interest at any time after the maturity date into shares of common stock of the Company at a price equal to $8.00/share of the principal. The note was paid off in September 2013.	$	-	$	25,000
	Convertible Promissory Note to an accredited investor dated May 20, 2003, maturing May 20, 2004, now due on demand, bearing interest at a rate 8% per annum payable in restricted shares of common stock. The Note is convertible at the option of the holder into common stock at the rate of $20.00 per share.		30,000		30,000
	One demand loan extended by an investor in March 2004 and January 2005, bearing interest at 12% per year, now due on demand. Principal in the amount of $5,000 was paid in September 2013.		10,000		15,000
	One promissory note issued to an accredited investors in May 2006, originally maturing in June 2006, due on demand. The note carried interest at the rate of 10% per year and is convertible into common shares at the rate of $20.00 /share. The note was acquired by a new investor and a new note was issued for the principal and accrued interest in August 2013.		-		25,000
	Two promissory notes issued to three accredited investors in September 2006, maturing at various dates between November 30, 2006 and January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		48,000		48,000
	One note was converted as of September 2, 2011 into common stock at the conversion price of $0.352 per share.
	Two promissory notes issued to three accredited investors in October 2006, maturing on January 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share. One note was converted as of September 2, 2011 into common stock at the conversion price of $0.352 per share.		44,000		44,000
	One promissory note issued to an accredited investors in January 2007, maturing on March 31, 2007, now due on demand. The notes carried interest at the rate of 10% per year until maturity and thereafter are subject to a rate of 14% per year, and are convertible into common shares at the rate of $20.00 /share.		75,000		75,000
	One promissory note issued to an accredited investor in May 2007, maturing on September 30, 2007, now due on demand. The note carried interest at the rate of 10% per year until maturity and thereafter is subject to a rate of 12% per year. The note calls for the interest payable in common stock, calculated at $8.00 per share. The note is convertible into common shares at the rate of $8.00 /share.		25,000		25,000
	Promissory note, originally in the amount of $2,710,563 issued to a service provider, due on July 31, 2008. The note carried interest at the rate of 10% per year compounded monthly. In November 2009, the creditor and the Company entered into an agreement whereby, against payment of $110,000 in cash, the principal amount of the note was reduced to $400,000.		400,000		400,000
	Two promissory notes, issued in November 2009 as part of a series of debt restructuring transactions whereby existing promissory notes, most of which were past due or payable on demand, and interest accrued thereon were exchanged into Units at the rate of 1 :1 between old note principal plus accrued interest to Unit price, at a price of $100,000 per Unit. Each Unit consisted of a 30 month promissory note for $100,000, carrying interest at 15% per year and 100 shares of Series F Convertible Preferred Stock, whereby every “F” share was converted into 120,000 common shares on April 20, 2010. The notes and interest accrued thereon are repayable in five quarterly installments beginning 18 months after issue. Six of the notes converted in September 2011 into Series G Convertible Preferred Stock at the rate of one share of G Preferred per $73.50 of principal and accrued interest. The Unit Note holders were entitled to a reduced conversion rate of one share of Series G Preferred per $50 of debt if they invested an amount equal to 25% of the principal amount of such holder’s Unit Note in the Series G Preferred equity offering. In April 2013, $67,021 of principal plus accrued interest was converted into 2,044 shares of Series G Preferred Stock, realizing a gain of $46,978.		85,726		152,747
	One promissory note issued to an accredited investor in March 2012, maturing September 23, 2013. The note carries interest at the rate of 10% per year until maturity and is payable quarterly in common stock valued at $0.20 per share. The note is convertible into common shares at the rate of $0.20 share. The note plus accrued interest was paid off in September 2013.		-		25,000
	Four promissory notes issued to an accredited investor in June and July 2012, maturing eight months after issuance. The notes carry interest at the rate of 24% per year. The notes and accrued interest were repaid in January 2013.		-		100,000
	One promissory note issued to an accredited investor in November 2012, maturing three months after issuance. The note carries interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		100,022
	One promissory note issued to an accredited investor in December 2012, maturing one month after issuance. The note carries interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		50,000
	One promissory note was issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The note is convertible into Series G Preferred Stock. The note bears interest at 10% per year and matures on March 31, 2015.		29,606		29,606
	Five promissory notes issued to accredited investors in March and April 2012, maturing thirty-six months after issuance. The note carries interest at the rate of 10% per year until maturity and are payable quarterly in common stock valued at $0.20 per share. The notes are convertible into common shares at the rate of $0.20 share. One note in the principal amount of $25,000 was paid off in January 2013.		74,306		39,584
	Two promissory notes issued to an accredited investor in March 2013, maturing twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes are convertible into common shares at the rate of $0.25/ share.		97,924		-
	Four notes issued to an accredited investor in April, May and June 2013, maturing between eight to twelve months after issuance. The notes carry interest at the rate of 15% per year until maturity. The notes and accrued interest were repaid in January 2014.		191,551		-
	One promissory note issued to an accredited investor in May 2013, maturing ten months after issuance. The note carries interest at the rate of 15% per year until maturity. The note is convertible into common shares at the rate of $0.20/ share.		96,012		-
	One promissory note issued to an accredited investor in May 2013, maturing nine months after issuance. The note carries interest at the rate of 15% per year until maturity. The note and accrued interest was repaid in February 2014.		95,948		-
	One promissory note re-issued to an accredited investor in August 2013, maturing seven months after re-issuance. The note carries interest at the rate of 10% per year until maturity. The note and accrued interest was repaid in January 2014.		53,000		-
	One promissory note issued to an accredited investor in August 2013, maturing six months after issuance. The note carries interest at the rate of 15% per year until maturity.		24,197		-
	Total Debt		1,380,270		1,183,959
	Less short-term portion		1,276,358		1,144,375
	Long-term portion	$	103,912	$	39,584
Schedule of long term debt	'
	Debt to affiliates is as follows:
		December 31,
		2013		2012
	Promissory note issued to an accredited investor in March 2009. The note was due on September 26, 2009 and carrying interest at 24% per year.	$	33,000	$	33,000
	Promissory note issued to an accredited investor in July 2009. The note was due on October 28, 2009 and carrying interest at 36% per year.		16,600		16,600
	Purchase order financing note issued in May 2010, carry interest at 24% per year and due on demand.		100,000		100,000
	One demand promissory note issued to an accredited investor in March 2012. The note carries interest at the rate of 12% per year and is payable quarterly in common stock valued at $0.20 per share. The note is convertible into common shares at the rate of $0.20 share. The note and accrued interest were repaid in January 2013.		-		75,000
	Eight promissory notes issued to accredited investors in June through September 2012, maturing eight months after issuance. The notes carry interest at the rate of 24% per year. The notes and accrued interest were repaid in January 2013.		-		264,000
	One promissory note issued to an accredited investor in October 2012 maturing four months after issuance. The notes carry interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		500,000
	Two promissory notes issued to accredited investors in December 2012 maturing one month after issuance. The notes carry interest at the rate of 24% per year. The note and accrued interest were repaid in January 2013.		-		27,500
Schedule of long term debt to related parties	'
	Long-Term Debt to affiliates is as follows:
		December 31,
		2013		2012
	Four promissory notes were issued as Senior Secured Convertible Notes in September 2011 as part of the Debt Reorganization and Financing Agreement dated July 14, 2011. The notes are convertible into common shares at a rate of $0.20/share. The notes bear interest at 10% per year and mature on March 31, 2015.	$	1,425,522	$	1,425,522
	Eight promissory notes issued to accredited investors in May through August 2013, maturing six to nine months after issuance. The notes carry interest at the rate of 15% per year.		2,104,584		-
	Four promissory notes issued to accredited investors in July 2013, maturing seven months after issuance. The notes carry interest at the rate of 12% per year.		589,544		-
	Total debt to affiliates		4,269,250		2,441,622
	Less short-term portion due to affiliates		2,843,728		2,441,622
	Total Long-Term Debt to affiliates	$	1,425,522	$	-
Schedule of Maturities of Long-term Debt	'
	The following is a schedule of future minimum debt payments as of December 31, 2013:
	Year Ending December 31,
	2014	$	4,269,250
	2015		1,380,270
	Total minimum payments required	$	5,649,520

INCOME_TAX_Tables

INCOME TAX (Tables)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Abstract]	'
Schedule of Effective Income Tax Rate Reconciliation	'
	The reconciliation of the effective income tax rate to the Federal statutory rate is as follows:
			2013			2012
	Federal Income Tax Rate		-34	%		-34	%
	State Income Tax, Net of Federal Benefit		-5.94	%		-5.94	%
	Change in valuation allowance		39.94	%		39.94	%
	Sale of New Jersey NOL		-46	%		-34	%
	Effective Income Tax Rate		-46	%		-34	%
Schedule of Deferred Tax Assets and Liabilities	'
	Significant components of the Company's deferred tax assets and liabilities are summarized as follows:
		December 31,
		2013			2012
	Deferred tax assets		23,165,000			21,190,000
	Less: Valuation Allowance		-23,165,000			-21,190,000
	Net Deferred Tax Assets	$	-		$	-

OPERATING_LEASE_LICENSE_AND_EM1

OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
Operating Lease And License And Employment Commitments [Abstract]	'
Schedule of Future Minimum Lease Rental Payments	'
	The following is a schedule of future minimum rental payments (exclusive of allocated expenses) required under operating leases that have initial or non-cancelable lease terms in excess of one year as of December 31, 2013:
	Year Ending December 31,
	2014	$	50,400
	2015		50,400
	2016		12,600
	Total minimum payments required	$	113,400
Schedule of Future Royalty Minimum Payment	'
	Year Ending December 31,
	2014	$	1,800,000
	2015		2,100,000
	2016		2,700,000
	2017		3,200,000
	2018		3,800,000
		$	13,600,000

SUMMARY_OF_SIGNIFICANT_ACCOUNT3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Mar. 31, 2014
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	'240 months	'	'
Amortization of Intangible Assets	$1,551	$576	'
Advertising Expense	8,157	261	'
Shipping Cost	43,299	8,065	'
Handling Cost	44,467	37,358	'
Stock Issued During Period, Shares, Share-based Compensation, Forfeited	1,140,000	7,500,000	'
Stock Issued During Period, Value, Share-based Compensation, Forfeited	206,700	457,500	'
Tax credit carryforward, amount	3,357,144	2,209,715	'
Tax certificate transfer program fee	302,143	198,875	'
Deferred Revenue	1,269,470	0	1,010,178
Deferred Cost Of Goods Sold	569,036	0	456,741
Unrecognized tax benefits resulting in net operating loss carryforward	$3,357,144	$5,187,471	'
Maximum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Property, Plant and Equipment, Useful Life	'8 years	'	'
Minimum [Member]	'	'	'
Summary Of Significant Accounting Policies [Line Items]	'	'	'
Property, Plant and Equipment, Useful Life	'3 years	'	'

Weighted_Average_Number_of_Sha

Weighted Average Number of Shares (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Potentially dilutive securities:	'	'
Convertible debt and accrued interest	10,751,345	10,775,363
Liability of shares to be issued	3,330,000	2,300,000
Convertible Preferred stock	49,713,545	37,929,545
Outstanding time-based warrants	19,323,406	18,190,906

GOING_CONCERN_AND_LIQUIDITY_IS1

GOING CONCERN AND LIQUIDITY ISSUES - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Going Concern [Line Items]	'	'	'
Accumulated deficit	($89,264,063)	($84,737,002)	($80,549,110)

Valuation_of_net_assets_acquir

Valuation of net assets acquired (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013
Purchase Price Allocation [Line Items]	'	'
Goodwill	$135,000	$135,000
Purchase Price	240,000	240,000
Trademarks	'	'
Purchase Price Allocation [Line Items]	'	'
Intangible assets	100,000	100,000
Customer Lists	'	'
Purchase Price Allocation [Line Items]	'	'
Intangible assets	$5,000	$5,000

BUSINESS_ACQUISITION_Additiona

BUSINESS ACQUISITION - Additional Information (Detail) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Business Acquisition [Line Items]	'	'
Payments to Acquire Businesses, Gross	$100,000	$100,000
Finite-Lived Intangible Asset, Useful Life	'5 years	'5 years
Series G Preferred Stock	'	'
Business Acquisition [Line Items]	'	'
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	8,000	8,000
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned	$140,000	$140,000

CONCENTRATIONS_OF_BUSINESS_AND1

CONCENTRATIONS OF BUSINESS AND CREDIT RISK - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	55.00%	57.00%
Customer One [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	31.00%	'
Customer Two [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	13.00%	'
Customer Three [Member]	'	'
Concentration Risk [Line Items]	'	'
Concentration Risk, Percentage	11.00%	'

Inventories_Detail

Inventories (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Inventory Disclosure [Line Items]	'	'	'
Finished Goods	$1,029,452	$378,472	$2,344
Work-in-process	'	0	49,200
Packaging	58,054	41,714	1,832
Inventory, gross, total	1,087,506	420,186	53,376
Less: Reserve for obsolescence	0	0	-49,200
Total	$1,087,506	$420,186	$4,176

Statement_of_Accounts_Payable_

Statement of Accounts Payable and Accrued Expenses (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Accounts Payable and Accrued Liabilities [Line Items]	'	'	'
Accounts payable	$2,527,020	$2,866,017	$1,224,313
Accrued interest	411,269	1,016,584	669,035
Accrued rent expense	135,874	135,874	135,874
Accrued salaries, bonuses and payroll taxes	143,648	824,492	612,712
Accrued professional fees	196,976	230,433	204,247
Owed to officers	5,650	16,088	0
Accounts payable and accrued expenses	$3,420,437	$5,089,488	$2,846,181

Unsecured_Notes_Net_Debt_Disco

Unsecured Notes Net Debt Discount (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Debt Instrument [Line Items]	'	'	'
Unsecured Convertible Notes	$1,261,867	$1,450,333	'
Debt discount	-72,512	-70,063	-135,417
Unsecured debt	1,189,355	1,380,270	'
Less long term portion	151,098	103,912	39,584
Short term portion	$1,038,257	$1,276,358	$1,144,375

SHORT_TERM_DEBT_NET_OF_DEBT_DI2

SHORT TERM DEBT, NET OF DEBT DISCOUNT - Additional Information (Detail) (USD $)

1 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

12 Months Ended

3 Months Ended

Jan. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Nov. 30, 2009

Mar. 31, 2014

Mar. 31, 2014

Dec. 31, 2013

Mar. 31, 2013

Mar. 31, 2013

Dec. 31, 2013

Jan. 31, 2014

Dec. 31, 2013

Nov. 30, 2009

Mar. 31, 2014

Mar. 31, 2014

Maximum [Member]

Minimum [Member]

One Affiliated Investor [Member]

One Affiliated Investor [Member]

Three Accredited Investors [Member]

Three Accredited Investors [Member]

Series G Preferred Stock

Notes Payble

Secured Promissory Unit Notes

Convertible Note 15%

Convertible Note 15%

Accredited Investor

Short-term Debt [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt outstanding

'

'

'

'

$85,726

'

'

$2,000,000

'

'

$249,535

'

$111,978

$85,726

'

'

Accrued interest

'

59,163

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible preferred stock, shares issued upon conversion

'

'

'

'

'

'

'

'

'

'

'

275,000

'

'

'

'

Debt payable and Accrued interest

'

111,978

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gains (losses) on restructuring of debt

'

41,578

46,978

0

'

'

'

'

'

'

'

'

'

'

'

'

Troubled debt restructuring, debtor, current period, gain (loss) on restructuring, per share, net

'

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from convertible debt

'

'

'

'

'

'

'

'

'

'

'

'

'

'

300,000

'

Proceeds from unsecured notes payable

'

'

'

'

'

'

'

2,000,000

'

'

249,535

'

'

'

'

300,000

Conversion price of note

'

'

$0.20

'

'

'

'

'

'

'

$0.20

'

'

'

'

'

Debt discount

'

72,512

70,063

135,417

'

'

'

'

'

'

'

'

'

'

77,207

'

Issuance of common stock (in shares)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

561,918

'

Proceeds From Sale Of Unsecured Convertible Notes Percentage

'

'

'

'

'

15.00%

12.00%

'

'

'

'

'

'

'

'

'

Debt Instrument, Fair Value Disclosure

'

'

1,096,487

'

'

'

'

1,791,713

'

'

223,548

'

'

'

'

'

Loss On Debt Modification Expense

'

'

'

'

'

'

'

'

208,287

25,987

'

'

'

'

'

'

Loss On Debt Restructuring

'

'

'

'

'

'

'

'

'

$0

'

'

'

'

'

'

Convertible Preferred Stock Value Issued Upon Conversion

$43,725

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

SHORT_TERM_DEBT_RELATED_PARTIE1

SHORT TERM DEBT - RELATED PARTIES, NET OF DEBT DISCOUNT - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Nov. 30, 2009	Mar. 31, 2014
					Convertible Notes Payable
Short Term Debt - Related Parties, Net Of Debt Discount [Line Items]	'	'	'	'	'
Proceeds from unsecured notes payable	'	'	'	'	$100
Debt instrument, interest rate, stated percentage	'	'	'	'	12.00%
Debt outstanding	'	'	'	85,726	100,000
Debt discount	$72,512	$70,063	$135,417	'	$26,740
Issuance of common stock (in shares)	'	'	'	'	125,000

Fair_Value_Hierarchy_For_Finan

Fair Value Hierarchy For Financial Assets Measured at Fair Value on Recurring Basis (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Derivative liability	$1,332,000	$318,000	$227,000
Total liabilities	1,332,000	318,000	227,000
Level I	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Derivative liability	0	'	'
Total liabilities	0	0	0
Level II	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Derivative liability	0	'	'
Total liabilities	0	0	0
Level III	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'
Derivative liability	1,332,000	318,000	227,000
Total liabilities	$1,332,000	$318,000	$227,000

Fair_Value_Liabilities_Measure

Fair Value Liabilities Measured on Recurring Basis Unobservable Input Reconciliation (Detail) (Derivative Liabilities [Member], USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013
Derivative Liabilities [Member]	'	'
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]	'	'
Balance at beginning of period	($318,000)	($227,000)
Derivative converted into Equity	-8,000	'
Change in fair market value of Conversion Feature	1,022,000	-91,000
Balance at end of period	$1,332,000	($318,000)

Warrant_Activity_Detail

Warrant Activity (Detail) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Class of Warrant or Right [Line Items]	'	'	'
Outstanding at Beginning, Shares	19,323,406	18,190,906	7,631,544
Warrants granted, Shares	0	1,140,000	10,587,500
Warrants exercised, Shares	-531,262	0	0
Warrants expired, Shares	0	-7,500	-28,138
Outstanding at end, Shares	18,792,144	19,323,406	18,190,906
Weighted Average Exercise Price, Outstanding at Beginning	$0.20	$0.23	$0.40
Warrants granted, Weighted Average Exercise Price	$0	$0.19	$0.13
Warrants exercised, Weighted Average Exercise Price	$0.10	$0	$0
Warrants expired, Weighted Average Exercise Price	$0	$60	$12,446
Weighted Average Exercise Price, Outstanding and exercisable at end	$0.20	$0.20	$0.23
Remaining Contractual Term, Outstanding at December 31, 2013	'63 months	'	'
Granted, Remaining Contractual Term	'55 months	'	'
Exercised, Remaining Contractual Term	'0 months	'	'
Expired or cancelled, Remaining Contractual Term	'0 months	'	'
Aggregate Intrinsic Value, Outstanding at December 31, 2013	$300,000	'	'
Granted, Aggregate Intrinsic Value	0	'	'
Exercised, Aggregate Intrinsic Value	0	'	'
Expired or cancelled, Aggregate Intrinsic Value	0	'	'
Aggregate Intrinsic Value, Outstanding and exercisable at March 31, 2014	$1,878,967	$300,000	'
Warrants exercise price range lower range limit	'	$0.10	$0.10
Warrants exercise price range upper range limit	'	$16	$60
Warrants price for exercised shares	'	$0	$0
Maximum	'	'	'
Class of Warrant or Right [Line Items]	'	'	'
Remaining Contractual Term, Outstanding and exercisable at March 31, 2014	'92 months	'	'
Minimum	'	'	'
Class of Warrant or Right [Line Items]	'	'	'
Remaining Contractual Term, Outstanding and exercisable at March 31, 2014	'11 months	'	'

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES - Additional Information (Detail) (USD $)	Mar. 31, 2014
Commitments and Contingencies [Line Items]	'
2014	$1,800,000
2015	2,100,000
2016	2,700,000
2017	3,200,000
2018	3,800,000
Minimum royalty payments total	$900,000

Debt_Detail

Debt (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Short-term Debt [Line Items]	'	'	'
Total Debt	'	$1,380,270	$1,183,959
Less short-term portion	'	1,276,358	1,144,375
Long-term portion	151,098	103,912	39,584
10% Promissory Note Maturing In September 2003	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	0	25,000
8% Convertable Promissory Note Maturing In May 2004	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	30,000	30,000
12% One demand loans	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	10,000	15,000
10% Promisssory Note Maturing In June 2006	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	0	25,000
10% Promisssory Note Maturing In November 30, 2006 and January 31, 2007	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	48,000	48,000
10% Promisssory Note Maturing In January 2007	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	44,000	44,000
10% Promisssory Note Maturing In March 2007	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	75,000	75,000
10% Promisssory Note Maturing In September 30, 2007	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	25,000	25,000
10% Promisssory Note due on July 31, 2008	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	400,000	400,000
2% Promissory Note Issued In November	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	85,726	152,747
10% Promisssory Note Maturing In September 2013	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	0	25,000
24% Promissory Note Maturing In June and July 2012	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	0	100,000
24% Promisssory Note Issued In November 2012	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	0	100,022
24% Promisssory Note Issued In December 2012	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	0	50,000
10% Senior Secured Convertible Notes In September 2011	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	29,606	29,606
10% Promissory notes Issued In March and April 2012	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	74,306	39,584
15% Promissory Note Issued In March 2013	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	97,924	0
15% Promissory Note Issued In April, May and June 2013	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	191,551	0
15% Promissory Notes Issuance One In May 2013	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	96,012	0
15% Promissory Note Issuance Two In May 2013	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	95,948	0
10% Promissory Notes Re Issuance In August 2013	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	53,000	0
15% Promissory Notes Issuance In August 2013	'	'	'
Short-term Debt [Line Items]	'	'	'
Total Debt	'	$24,197	$0

Debt_Parenthetical_Detail

Debt (Parenthetical) (Detail) (USD $)

3 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

12 Months Ended

Mar. 31, 2014

Mar. 31, 2013

Dec. 31, 2013

Dec. 31, 2012

Jan. 31, 2014

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Sep. 02, 2011

Dec. 31, 2013

Sep. 02, 2011

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Dec. 31, 2013

Series G Preferred Stock

10% Promissory Note Maturing In September 2003

8% Convertable Promissory Note Maturing In May 2004

12% One demand loans

10% Promissory Note Maturing In June 2006

10% Promissory Note Maturing In November 30, 2006 and January 31, 2007

10% Promissory Note Maturing In November 30, 2006 and January 31, 2007

10% Promissory Note Maturing In January 2007

10% Promissory Note Maturing In January 2007

10% Promissory Note Maturing In March 2007

10% Promissory Note Maturing In September 2007

10% Promissory Note due on July 31, 2008

15% Promissory Note In November

15% Promissory Note In November

15% Promissory Note In November

10% Promissory Note Maturing In September 2013

24% Promissory Note In June and July 2012

24% Promissory Note In November 2012

24% Promissory Note In December 2012

10% Promissory Note In September 2011

10% Promissory Note In March and April 2012

15% Promissory Note In March 2013

15% Promissory Note In April, May and June 2013

15% Promissory Note In May 2013, maturing ten months

15% Promissory Note In May 2013, maturing nine months

15% Promissory Note In August 2013 maturing six months

10% Promissory Note In August 2013 maturing seven months

Maximum

Minimum

Series F Preferred Stock

Series G Preferred Stock

10% Promissory Note Maturing In November 30, 2006 and January 31, 2007

10% Promissory Note Maturing In November 30, 2006 and January 31, 2007

Debt Parenthetical [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

28-Sep-03

20-May-04

'

30-Jun-06

'

'

31-Jan-07

'

31-Mar-07

30-Sep-07

31-Jul-08

'

'

'

23-Sep-13

31-Jan-13

31-Jan-13

31-Jan-13

31-Mar-15

31-Jan-13

'

31-Jan-14

'

28-Feb-14

'

31-Jan-14

31-Jan-07

30-Nov-06

Debt Instrument, Interest Rate During Period

'

'

'

'

'

10.00%

8.00%

12.00%

10.00%

10.00%

'

10.00%

'

10.00%

10.00%

10.00%

15.00%

'

'

10.00%

24.00%

24.00%

24.00%

10.00%

10.00%

15.00%

15.00%

15.00%

15.00%

15.00%

10.00%

'

'

Debt Instrument, Convertible, Conversion Price

'

'

$0.20

'

'

$8

$20

'

$20

$20

$0.35

$20

$0.35

$20

$8

'

'

'

$73.50

$0.20

'

'

'

$0.25

$0.20

$0.25

'

$0.20

'

'

'

'

'

Debt Conversion, Converted Instrument, Amount

$258,438

$441,900

'

'

'

'

'

$5,000

'

'

'

'

'

'

'

$400,000

'

'

$2,044

'

'

'

'

'

$25,000

'

'

'

'

'

'

'

'

Debt Instrument Debt Default Interest Rate During Period

'

'

'

'

'

'

'

'

'

14.00%

'

14.00%

'

14.00%

12.00%

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument Accrued Interest Convertible Conversion Price

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$8

'

'

'

'

$0.20

'

'

'

'

$0.20

'

'

'

'

'

'

'

'

Debt Instrument, Face Amount

1,261,867

'

1,450,333

'

'

'

'

'

'

'

'

'

'

'

'

2,710,563

'

'

67,021

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of Short-term Debt, Total

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

110,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Interest Accrued Exchanged Into Promissory Note Units Rate

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Units at the rate of 1:1

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Promissory Note Units Per Value

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$100,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument Debt Default Stock Issued

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Convertible Preferred Stock, Shares Issued upon Conversion

'

'

'

'

275,000

'

'

'

'

'

'

'

'

'

'

'

'

120,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Contingent Debt Instrument Convertible Conversion Price Description

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'Reduced conversion rate of one share of Series G Preferred per $50 of debt if they invested an amount equal to 25% of the principal amount of such holder's Unit Note in the Series G Preferred equity offering.

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Financing Agreement Dated

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

14-Jul-11

'

'

'

'

'

'

'

'

'

Gains (Losses) on Extinguishment of Debt

$15,591

$0

$46,978

$0

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt_to_Affiliates_Detail

Debt to Affiliates (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
24% Promisssory Note Maturing In September 2009	'	'
Short-term Debt [Line Items]	'	'
Due to Related Parties	$33,000	$33,000
36% Percent Promissory Note Maturing In October 2009	'	'
Short-term Debt [Line Items]	'	'
Due to Related Parties	16,600	16,600
24% Demand Note	'	'
Short-term Debt [Line Items]	'	'
Due to Related Parties	100,000	100,000
12% Promissory Note Maturing In January 2013	'	'
Short-term Debt [Line Items]	'	'
Due to Related Parties	0	75,000
24% Promissory Note Maturing In May 2013	'	'
Short-term Debt [Line Items]	'	'
Due to Related Parties	0	264,000
24% Promissory Note Maturing In February 2013	'	'
Short-term Debt [Line Items]	'	'
Due to Related Parties	0	500,000
24% promissory note maturing in January 2013	'	'
Short-term Debt [Line Items]	'	'
Due to Related Parties	$0	$27,500

Debt_to_Affiliates_Parenthetic

Debt to Affiliates (Parenthetical) (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Debt Instrument [Line Items]	'
Debt Instrument, Convertible, Conversion Price	0.2
24% Promissory Note Maturing In September 2009	'
Debt Instrument [Line Items]	'
Debt Instrument, Maturity Date	26-Sep-09
Debt instrument interest rate	24.00%
36% Percent Promissory Note October 2009	'
Debt Instrument [Line Items]	'
Debt Instrument, Maturity Date	28-Oct-09
Debt instrument interest rate	36.00%
24% Demand Note	'
Debt Instrument [Line Items]	'
Debt instrument interest rate	24.00%
12% Promissory Note Maturing In January 2013	'
Debt Instrument [Line Items]	'
Debt Instrument, Maturity Date	31-Jan-13
Debt instrument interest rate	12.00%
Debt Instrument Accured Interest Convertible Conversion Price	0.2
Debt Instrument, Convertible, Conversion Price	0.2
24% of Eight Promissory Note Maturing In January 2013	'
Debt Instrument [Line Items]	'
Debt Instrument, Maturity Date	31-Jan-13
Debt instrument interest rate	24.00%
24% of One Promissory Note Maturing In January 2013	'
Debt Instrument [Line Items]	'
Debt Instrument, Maturity Date	31-Jan-13
Debt instrument interest rate	24.00%
24% of Two Promissory Note Maturing In January 2013	'
Debt Instrument [Line Items]	'
Debt Instrument, Maturity Date	31-Jan-13
Debt instrument interest rate	24.00%

Long_Term_Debt_to_Affiliates_D

Long Term Debt to Affiliates (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Long Term Debt Noncurrent [Line Items]	'	'	'
Long term debt noncurrent	'	$1,380,270	$1,183,959
Less short-term portion due to affiliates	'	1,276,358	1,144,375
Total Long-Term Debt to affiliates	151,098	103,912	39,584
Senior Secured Convertible Notes	'	'	'
Long Term Debt Noncurrent [Line Items]	'	'	'
Total Long-Term Debt to affiliates	'	1,425,522	1,425,522
15% Eight Promissory Note	'	'	'
Long Term Debt Noncurrent [Line Items]	'	'	'
Total Long-Term Debt to affiliates	'	2,104,584	0
12% Four Promissory Note	'	'	'
Long Term Debt Noncurrent [Line Items]	'	'	'
Total Long-Term Debt to affiliates	'	589,544	0
Affiliates	'	'	'
Long Term Debt Noncurrent [Line Items]	'	'	'
Long term debt noncurrent	'	4,269,250	2,441,622
Less short-term portion due to affiliates	'	2,843,728	2,441,622
Total Long-Term Debt to affiliates	'	$1,425,522	$0

Long_Term_Debt_to_Affiliates_P

Long Term Debt to Affiliates (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2013
Senior Secured Convertible Notes	'
Long Term Debt To Related Parties [Line Items]	'
Debt instrument interest rate	10.00%
Debt Instrument, Maturity Date	31-Mar-15
15% Eight Promissory Note	'
Long Term Debt To Related Parties [Line Items]	'
Debt instrument interest rate	15.00%
12% Four Promissory Note	'
Long Term Debt To Related Parties [Line Items]	'
Debt instrument interest rate	12.00%

Future_Minimum_Debt_Payments_D

Future Minimum Debt Payments (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Year Ending December 31,	'
2014	$4,269,250
2015	1,380,270
Total minimum payments required	$5,649,520

DEBT_Additional_Information_De

DEBT - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2012
				Unit Notes [Member]	Promissory Note	Promissory Note	Promissory Note	Convertible Debt [Member]
							Investor Group [Member]
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'
Long-term Debt, Total	'	$1,380,270	$1,183,959	'	$4,269,250	$2,441,622	'	'
Debt Instrument, Unamortized Discount	72,512	70,063	135,417	'	82,560	0	'	391,000
Debt Instrument, Convertible, Carrying Amount of Equity Component	'	'	391,000	'	'	'	'	1,100,000
Incremental Carrying Value Of Instruments Issued In Excess Of Debt	'	'	736,000	'	'	'	'	'
Notes Payable, Total	'	'	'	1,455,128	'	'	'	'
Debt Instrument, Fair Value Disclosure	'	1,096,487	'	'	'	'	'	'
Convertible Debt, Fair Value Disclosures	'	358,641	'	'	'	'	'	'
Debt Instrument, Convertible, Conversion Price	'	$0.20	'	'	'	'	'	'
Other Nonoperating Gains (Losses)	'	'	'	'	'	'	$358,641	'

Reconciliation_of_Effective_In

Reconciliation of Effective Income Tax Rate (Detail)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Effective Income Tax Rate Reconciliation [Line Items]	'	'
Federal Income Tax Rate	-34.00%	-34.00%
State Income Tax, Net of Federal Benefit	-5.94%	-5.94%
Change in valuation allowance	39.94%	39.94%
Sale of New Jersey NOL	-46.00%	-34.00%
Effective Income Tax Rate	-46.00%	-34.00%

Deferred_Tax_Assets_and_Liabil

Deferred Tax Assets and Liabilities (Detail) (USD $)	Dec. 31, 2013	Dec. 31, 2012
Schedule Of Deferred Tax Assets And Liabilities [Line Items]	'	'
Deferred tax assets	$23,165,000	$21,190,000
Less: Valuation Allowance	-23,165,000	-21,190,000
Net Deferred Tax Assets	$0	$0

INCOME_TAX_Additional_informat

INCOME TAX - Additional information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Income Tax Disclosure [Line Items]	'
Operating Loss carryforwards	$57,000,000
Operating Loss Carryforward Expiration Date	'Net operating loss carry forwards expire starting in 2024 through 2032.
Valuation allowance, deferred tax asset, change in amount	1,975,000
Deferred Tax Asset Valuation Allowance	$23,165,000

Temporary_Equity_Detail

Temporary Equity (Detail) (USD $)	Dec. 31, 2013		Dec. 31, 2012
Convertible Series B	'		'
Temporary Equity [Line Items]	'		'
Number of common shares to be issued upon conversion of each preferred share	10		10
Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)	$2		$2
Cumulative Series C	'		'
Temporary Equity [Line Items]	'		'
Number of common shares to be issued upon conversion of each preferred share	0		0
Redemption price and involuntary liquidation value per preferred shares (if redeemed, ranking would be Convertible Series D then , Convertible Series B then Cumulative Series C)	$10	[1]	$10	[1]
[1]	Plus any dividend in arrears.

CAPITAL_STOCK_Additional_Infor

CAPITAL STOCK - Additional Information (Detail) (USD $)

12 Months Ended

12 Months Ended

0 Months Ended

12 Months Ended

12 Months Ended

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2012

Mar. 15, 2010

Mar. 31, 2014

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Mar. 31, 2014

Dec. 31, 2012

Dec. 31, 2013

Common Stock [Member]

Series C Preferred Stock

Series C Preferred Stock

Series C Preferred Stock

Series E Preferred Stock

Series E Preferred Stock

Series E Preferred Stock

Series E Preferred Stock

Series F Preferred Stock

Series F Preferred Stock

Series F Preferred Stock

Series G Preferred Stock

Capital Stock [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, dividend rate, per-dollar-amount

'

'

'

'

$0.65

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares authorized

'

'

'

'

'

'

'

'

'

50,000

'

10,000

'

'

400,000

Preferred stock, par value

'

'

'

'

$1

$1

$1

'

$1

$1

$1

$1

$1

$1

$1

Preferred stock, value, outstanding

'

'

'

'

'

'

'

'

'

'

'

$10,000,000

'

'

'

Preferred stock conversion rate

'

'

'

'

'

'

'

10,000

'

'

'

120,000

'

'

250

Preferred stock stated value per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$50

Preferred stock, dividend payment terms

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'The shares of G Preferred shall bear a 10% annual dividend, payable quarterly in kind based on the equivalent of 90% of the average of the last ten trading day closing price of the Common Stock prior to the dividend payment date.

Common stock, shares authorized

2,000,000,000

2,000,000,000

2,000,000,000

2,000,000,000

'

'

'

'

'

'

'

'

'

'

'

Common stock, par value

$0.00

$0.00

$0.00

$0.00

'

'

'

'

'

'

'

'

'

'

'

Unrecognized compensation cost related to non-vested warrant

$43,125

'

'

$43,125

'

'

'

'

'

'

'

'

'

'

'

Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition

'2 years

'

'

'2 years

'

'

'

'

'

'

'

'

'

'

'

Fixed_Price_Stock_Options_and_

Fixed Price Stock Options and Warrants Outstanding (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding at December 31,2013	19,323,406
Number Exercisable at December 31, 2013	18,190,906
Exercise price zero point one	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding at December 31,2013	7,500,000
Average Remaining Contractual Life	'47 months
Weighted Average Exercise Price	$0.10
Number Exercisable at December 31, 2013	7,500,000
Weighted Average Exercise Price	$0.10
Exercise price zero point one seven	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding at December 31,2013	8,033,406
Average Remaining Contractual Life	'92 months
Weighted Average Exercise Price	$0.17
Number Exercisable at December 31, 2013	7,533,406
Weighted Average Exercise Price	$0.17
Exercise price zero point two	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding at December 31,2013	3,727,500
Average Remaining Contractual Life	'16 months
Weighted Average Exercise Price	$0.20
Number Exercisable at December 31, 2013	3,087,500
Weighted Average Exercise Price	$0.20
Exercise price sixteen point zero	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding at December 31,2013	62,500
Average Remaining Contractual Life	'72 months
Weighted Average Exercise Price	$16
Number Exercisable at December 31, 2013	62,500
Weighted Average Exercise Price	$16
Exercise price sixty point zero	'
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]	'
Number Outstanding at December 31,2013	0
Weighted Average Exercise Price	$60
Number Exercisable at December 31, 2013	7,500
Weighted Average Exercise Price	$60

OPTIONS_AND_WARRANTS_Additiona

OPTIONS AND WARRANTS - Additional Information (Detail) (USD $)	12 Months Ended			1 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Feb. 29, 2000	Feb. 29, 2000	Feb. 29, 2000
			Warrant [Member]	Individual Owns More Than 10% Voting Power	Non-Qualified Stock Options	2001 Stock Option Plan
			Officer
Options And Warrants [Line Items]	'	'	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	'	'	'	'	'	500,000
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent	'	'	'	110.00%	85.00%	100.00%
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense	$457,500	$1,280,679	'	'	'	'
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized	$43,125	'	'	'	'	'
Employee service share-based compensation, nonvested awards, total compensation cost not yet recognized, period for recognition	'2 years	'	'	'	'	'
Stock Issued During Period, Shares, New Issues	'	'	3,000,000	'	'	'
Fair Value Assumptions, Exercise Price	'	'	$0.10	'	'	'
Share Price	'	'	$0.10	'	'	'
Fair Value Assumptions, Expected Volatility Rate	'	'	177.45%	'	'	'
Fair Value Assumptions, Expected Term	'	'	'5 years	'	'	'
Fair Value Assumptions, Risk Free Interest Rate	'	'	2.50%	'	'	'
Fair Value Assumptions, Expected Dividend Rate	'	'	0.00%	'	'	'

Future_Minimum_Lease_Rental_Pa

Future Minimum Lease Rental Payments (Detail) (USD $)	Dec. 31, 2013
Future Minimum Lease Rental Payments [Line Items]	'
2014	$50,400
2015	50,400
2016	12,600
Total minimum payments required	$113,400

Future_Royalty_Minimum_Payment

Future Royalty Minimum Payment (Detail) (USD $)	Dec. 31, 2013
Future Royalty Minimum Payment [Line Items]	'
2014	$1,800,000
2015	2,100,000
2016	2,700,000
2017	3,200,000
2018	3,800,000
Future minimum royalty payments due	$13,600,000

OPERATING_LEASE_LICENSE_AND_EM2

OPERATING LEASE, LICENSE AND EMPLOYMENT COMMITMENTS - Additional Information (Detail) (USD $)	12 Months Ended			12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Jul. 14, 2011	Dec. 31, 2013	Dec. 31, 2013
			Mr. James	Mr. Germano	Mr. Germano
					Series E Preferred Stock
Leases, Operating [Line Items]	'	'	'	'	'
Operating leases, rent expense	$47,282	$37,928	'	'	'
Royalty expense	450,000	'	'	'	'
Revised annual salary, current	'	'	150,000	'	'
Revised annual salary, after three fiscal quarters	'	'	200,000	'	'
Bonus payable after three fiscal quarters	'	'	$25,000	'	'
Amended and restated employment agreement description	'	'	'	'Pursuant to the Agreement, Mr. Germano currently receives a base annual salary of $150,000 per year which increases to $200,000 per year in the event (a) the Company's annual revenues exceed $15,000,000; (b) the Company enters into a licensing agreement with an unrelated third party where the minimum upfront licensing fee is no less than $3,000,000; or (c) the Company achieves two quarters of positive cash flow	'
Share-based compensation arrangement by share-based payment award, shares issued in period	'	'	'	'	114.1667
Stock issued during period, shares, conversion of convertible securities	'	'	'	18,021	'

STOCK_GRANTED_FOR_SERVICES_AND1

STOCK GRANTED FOR SERVICES AND FINANCING - Additional Information (Detail) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Dec. 31, 2012
Stock Based Compensation Disclosure [Line Items]	'	'	'	'
Issuance of common for services	'	'	$324,270	$3,284,250
Share-based Compensation	1,323,883	450,600	505,509	17,300
Common Stock	'	'	'	'
Stock Based Compensation Disclosure [Line Items]	'	'	'	'
Issuance of common stock for services (in shares)	'	'	1,637,500	11,395,000
Issuance of common for services	'	'	1,637	11,395
Service | Common Stock	'	'	'	'
Stock Based Compensation Disclosure [Line Items]	'	'	'	'
Issuance of common stock for services (in shares)	'	'	1,637,500	'
Issuance of common for services	'	'	202,270	'
Service | Convertible Series G	'	'	'	'
Stock Based Compensation Disclosure [Line Items]	'	'	'	'
Issuance of common stock for services (in shares)	'	'	4,000	'
Issuance of common for services	'	'	$122,000	'

RELATED_PARTY_TRANSACTIONS_Add

RELATED PARTY TRANSACTIONS - Additional Information (Detail) (USD $)	Mar. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Jan. 31, 2013	Jan. 31, 2013	Jan. 31, 2013
				Officer	Mr. James	Mr. Germano	Mr. DeLucia
				Warrant
Related Party Transaction [Line Items]	'	'	'	'	'	'	'
Common stock, issued	73,229,104	62,461,448	48,707,103	'	2,000,000	2,000,000	500,000
Common Stock, Value, Issued	$73,230	$62,462	$48,708	'	$150,200	$150,200	$50,000
Stock Issued During Period, Shares, New Issues	'	'	'	3,000,000	'	'	'
Fair Value Assumptions, Exercise Price	'	'	'	$0.10	'	'	'
Share Price	'	'	'	$0.10	'	'	'
Fair Value Assumptions, Expected Volatility Rate	'	'	'	177.45%	'	'	'
Fair Value Assumptions, Expected Term	'	'	'	'5 years	'	'	'
Fair Value Assumptions, Risk Free Interest Rate	'	'	'	2.50%	'	'	'
Fair Value Assumptions, Expected Dividend Rate	'	'	'	0.00%	'	'	'

LITIGATION_Additional_Informat

LITIGATION - Additional Information (Detail) (USD $)	12 Months Ended
	Dec. 31, 2013
Robert Half International	'
Litigation Settlements [Line Items]	'
Malpractice loss contingency, settlement of claims	$18,507
Creative Healthcare Solutions, LLC	'
Litigation Settlements [Line Items]	'
Percentage of materials destroy and dispose	80.00%
Loss Contingency, Damages Sought, Value	$63,718

SUBSEQUENT_EVENTS_Additional_I

SUBSEQUENT EVENTS - Additional Information (Detail) (USD $)

3 Months Ended

12 Months Ended

12 Months Ended

1 Months Ended

3 Months Ended

1 Months Ended

3 Months Ended

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Jan. 31, 2014

Dec. 31, 2011

Nov. 30, 2009

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2014

Sep. 30, 2013

Sep. 30, 2013

Jan. 31, 2013

Feb. 28, 2014

Jan. 31, 2014

Jan. 23, 2014

Mar. 31, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Jun. 30, 2014

Common Stock

Common Stock

Director

Investor

Investor

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Subsequent Event

Seahorse Enterprises, Llc

Common Stock

12% Secured Subordinated Convertible Promissory Note

Offier and Employee

Officer And Related Entity

Accredited Investor 1

Accredited Investor 2

Subsequent Event

Subsequent Event [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Receivable From Technology Business Tax Certificate Transfer Program

'

$3,357,144

$2,209,715

$0

'

'

'

'

'

'

'

'

'

'

'

$3,357,144

'

'

'

'

'

Tax Certificate Transfer Program Fee

'

302,143

198,875

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Net Tax Credit Carryforward Amount

'

3,055,001

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Repayments of Notes Payable

'

'

'

'

'

'

'

'

'

'

'

'

528,000

'

'

'

'

'

'

'

'

Common Stock, Capital Shares Reserved for Future Issuance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4,750,000

'

'

'

'

Stock Issued During Period, Shares, Acquisitions

'

'

'

'

'

'

'

'

'

500,000

'

'

'

'

'

'

'

'

'

'

'

Preferred stock, shares issued

'

'

'

'

10,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Effective Preferred Stock Shares Authorized

'

'

'

'

'

'

'

'

'

'

'

'

'

400,000

'

'

'

'

'

'

'

Loans payable

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,000,000

'

'

'

'

'

'

Long-term Debt, Gross

'

'

'

'

'

'

85,726

'

'

'

'

'

'

'

'

'

'

200,000

100,000

110,000

785,000

Debt Instrument, Interest Rate, Effective Percentage

'

'

'

'

'

'

'

'

'

'

'

12.00%

'

'

'

'

'

12.00%

15.00%

'

12.00%

Debt Instrument Maturity Period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'9 months

'18 months

'

'9 months

Stock Issued During Period, Shares, Other

'

'

'

'

'

'

'

2,851,711

895,184

'

'

'

'

'

'

'

'

'

125,000

'

'

Debt Instrument, Maturity Date

'

'

'

'

'

'

'

'

'

'

'

14-Jul-15

'

'

'

'

'

'

'

1-Dec-14

'

Proceeds from Notes Payable

'

'

'

'

'

'

'

'

'

'

'

1,000,000

'

'

'

'

'

'

'

'

'

Convertible Subordinated Debt

'

'

'

'

'

'

'

'

'

'

'

$1,500,000

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Outstanding

'

19,323,406

18,190,906

18,792,144

'

7,631,544

'

'

'

'

2,500,000

'

'

'

'

'

'

'

'

'

'

Description On Resale Of Shares Issuable Upon Conversion Of Note And Exercise Of Warrant

'the principal amount of the Note shall be reduced by $200,000, and if the registration statement is declared effective by the SEC within 120 days of July 14, 2014, the principal amount of the Notes shall be further reduced by $300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Description On Common Stock Conversion Price

'Principal and accrued but unpaid interest is convertible into shares of the Companys Common Stock at a price (the Conversion Price) equal the lesser (i) $0.35 per share, or (ii) 62% of the lowest trading price of the Common Stock as quoted by Bloomberg L.P. for the ten trading days immediately preceding the date of conversion (subject to adjustments as provided in the Note). However, in no event shall the Conversion Price be less than $0.031 per share

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'